<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35137496</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-8027</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of the peripheral nervous system : JPNS</Title><ISOAbbreviation>J Peripher Nerv Syst</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.</ArticleTitle><Pagination><StartPage>4</StartPage><EndPage>30</EndPage><MedlinePgn>4-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jns.12482</ELocationID><Abstract><AbstractText>Increasing literature has linked COVID-19 to peripheral nervous system (PNS) diseases. In addition, as we move from the pandemic to the vaccination era, literature interest is shifting towards the potential association between COVID-19 vaccines and PNS manifestations. We reviewed published literature on COVID-19, COVID-19 vaccines and PNS manifestations between 1 January 2020 and 1 December 2021. For Guillain-Barr&#xe9; syndrome (GBS), isolated cranial neuropathy (ICN) and myositis associated with COVID-19, the demographic, clinical, laboratory, electrophysiological and imaging features were included in a narrative synthesis. We identified 169 studies on COVID-19-associated complications, including 63 papers (92 patients) on GBS, 29 papers (37 patients) on ICN and 11 papers (18 patients) on myositis. Additional clinical phenotypes included chronic inflammatory demyelinating polyneuropathy, vasculitic neuropathies, neuralgic amyotrophy, critical care-related complications, and myasthenia gravis. PNS complications secondary to COVID-19 vaccines have been reported during randomized clinical trials, in real-world case reports, and during large-scale surveillance programs. These mainly include cases of GBS, Bell's palsy, and cases of neuralgic amyotrophy. Based on our extensive review of the literature, any conclusion about a pathophysiological correlation between COVID-19 and PNS disorders remains premature, and solely supported by their temporal association, while epidemiological and pathological data are insufficient. The occurrence of PNS complications after COVID-19 vaccines seems limited to a possible higher risk of facial nerve palsy and GBS, to a degree that widespread access to the ongoing vaccination campaign should not be discouraged, while awaiting for more definitive data from large-scale surveillance studies.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of the Peripheral Nervous System published by Wiley Periodicals LLC on behalf of Peripheral Nerve Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taga</LastName><ForeName>Arens</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7059-3604</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauria</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9773-020X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Peripher Nerv Syst</MedlineTA><NlmUniqueID>9704532</NlmUniqueID><ISSNLinking>1085-9489</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017933" MajorTopicYN="N">Peripheral Nervous System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CIDP</Keyword><Keyword MajorTopicYN="N">Guillain-Barr&#xe9; syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cranial neuropathy</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mononeuritis multiplex</Keyword><Keyword MajorTopicYN="N">myopathy</Keyword><Keyword MajorTopicYN="N">neuralgic amyotrophy</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35137496</ArticleId><ArticleId IdType="pmc">PMC9115278</ArticleId><ArticleId IdType="doi">10.1111/jns.12482</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lapostolle F, Schneider E, Vianu I, et al. Clinical features of 1487 COVID&#x2010;19 patients with outpatient management in the Greater Paris: the COVID&#x2010;call study. Intern Emerg Med. 2020;15:813&#x2010;817. doi:10.1007/s11739-020-02379-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02379-z</ArticleId><ArticleId IdType="pmc">PMC7260461</ArticleId><ArticleId IdType="pubmed">32474850</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero&#x2010;S&#xe1;nchez CM, D&#xed;az&#x2010;Maroto I, Fern&#xe1;ndez&#x2010;D&#xed;az E, et al. Neurologic manifestations in hospitalized patients with COVID&#x2010;19: The ALBACOVID registry. Neurology. 2020;95:e1060&#x2010;e1070. doi:10.1212/WNL.0000000000009937</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Place S, van Laethem Y, et al. Clinical and epidemiological characteristics of 1420 European patients with mild&#x2010;to&#x2010;moderate coronavirus disease 2019. J Intern Med. 2020;288:335&#x2010;344. doi:10.1111/joim.13089</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13089</ArticleId><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Khedr EM, Abo&#x2010;Elfetoh N, Deaf E, et al. Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID&#x2010;19 in Assiut and Aswan University Hospitals. Neuroepidemiology. 2021;55:109&#x2010;118. doi:10.1159/000513647</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513647</ArticleId><ArticleId IdType="pmc">PMC8018217</ArticleId><ArticleId IdType="pubmed">33631765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2010;690. doi:10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifino N, Censori B, Agazzi E, et al. Neurologic manifestations in 1760 COVID&#x2010;19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol. 2021;268(7):2331&#x2010;2338. doi:10.1007/s00415-020-10251-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10251-5</ArticleId><ArticleId IdType="pmc">PMC7539268</ArticleId><ArticleId IdType="pubmed">33026520</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID&#x2010;19 in 153 patients: a UK&#x2010;wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2010;882. doi:10.1016/S2215-0366(20)30287-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, et al. A prospective study of neurologic disorders in hospitalized patients with COVID&#x2010;19 in New York City. Neurology. 2021;96:e575&#x2010;e586. doi:10.1212/WNL.0000000000010979</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010979</ArticleId><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong W, Mu J, Guo J, et al. New onset neurologic events in people with COVID&#x2010;19 in 3 regions in China. Neurology. 2020;95:e1479&#x2010;e1487. doi:10.1212/WNL.0000000000010034</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010034</ArticleId><ArticleId IdType="pubmed">32554771</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano GS, Woods JK, Amato AA. Covid&#x2010;19&#x2010;Associated myopathy caused by type I interferonopathy. N Engl J Med. 2020;383:2389&#x2010;2390. doi:10.1056/NEJMc2031085</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031085</ArticleId><ArticleId IdType="pmc">PMC7722689</ArticleId><ArticleId IdType="pubmed">33216474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan I, Saif&#x2010;Ur&#x2010;Rahman KM, Hayat S, et al. Guillain&#x2010;Barre syndrome associated with SARS&#x2010;CoV&#x2010;2 infection: a systematic review and individual participant data meta&#x2010;analysis. J Peripher Nerv Syst. 2020;25:335&#x2010;343. doi:10.1111/jns.12419</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12419</ArticleId><ArticleId IdType="pubmed">33112450</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu&#x2010;Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain&#x2010;Barre syndrome spectrum associated with COVID&#x2010;19: an up&#x2010;to&#x2010;date systematic review of 73 cases. J Neurol. 2021;268:1133&#x2010;1170. doi:10.1007/s00415-020-10124-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10124-x</ArticleId><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS&#x2010;CoV2 may play a role in the respiratory failure of COVID&#x2010;19 patients. J Med Virol. 2020;92:552&#x2010;555. doi:10.1002/jmv.25728</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77:1018&#x2010;1027. doi:10.1001/jamaneurol.2020.2065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Canetta C, Accordino S, Buscarini E, et al. Syncope at SARS&#x2010;CoV&#x2010;2 onset. Auton Neurosci. 2020;229:102734. doi:10.1016/j.autneu.2020.102734</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2020.102734</ArticleId><ArticleId IdType="pmc">PMC7505046</ArticleId><ArticleId IdType="pubmed">32977101</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann B, Schmidbauer ML, Dimitriadis K, et al. Cerebrospinal fluid findings in COVID&#x2010;19 patients with neurological symptoms. J Neurol Sci. 2020;418:117090. doi:10.1016/j.jns.2020.117090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117090</ArticleId><ArticleId IdType="pmc">PMC7417278</ArticleId><ArticleId IdType="pubmed">32805440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Frontera J, Placantonakis DG, et al. Cerebrospinal fluid in COVID&#x2010;19: A systematic review of the literature. J Neurol Sci. 2021;421:117316. doi:10.1016/j.jns.2021.117316</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117316</ArticleId><ArticleId IdType="pmc">PMC7833669</ArticleId><ArticleId IdType="pubmed">33561753</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P, et al. Cerebrospinal fluid findings in COVID&#x2010;19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19:19. doi:10.1186/s12974-021-02339-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou JJ, Movassaghi M, Gordy D, et al. Neuropathology of COVID&#x2010;19 (neuro&#x2010;COVID): clinicopathological update. Free Neuropathol. 2021;2:2. doi:10.17879/freeneuropathology-2021-2993</Citation><ArticleIdList><ArticleId IdType="doi">10.17879/freeneuropathology-2021-2993</ArticleId><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al. Neuropathology of patients with COVID&#x2010;19 in Germany: a post&#x2010;mortem case series. Lancet Neurol. 2020;19:919&#x2010;929. doi:10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz&#x2010;Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus&#x2010;2 (SARS&#x2010;CoV&#x2010;2). J Med Virol. 2020;92:699&#x2010;702. doi:10.1002/jmv.25915</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbini P, Verga L, Pagella FGM, et al. Ultrastructural evidence of direct viral damage to the olfactory complex in patients testing positive for SARS&#x2010;CoV&#x2010;2. JAMA Otolaryngol Head Neck Surg. 2020;146(10):972&#x2010;973. doi:10.1001/jamaoto.2020.2366</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.2366</ArticleId><ArticleId IdType="pubmed">32790835</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J, Mukerji SS, Collens SI, et al. Skeletal muscle and peripheral nerve histopathology in COVID&#x2010;19. Neurology. 2021;97:e849&#x2010;e858. doi:10.1212/WNL.0000000000012344</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012344</ArticleId><ArticleId IdType="pubmed">34099523</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, de Vries HJ, Vlaar APJ, et al. Diaphragm pathology in critically ill patients with COVID&#x2010;19 and postmortem findings from 3 medical centers. JAMA Intern Med. 2021;181:122&#x2010;124. doi:10.1001/jamainternmed.2020.6278</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.6278</ArticleId><ArticleId IdType="pmc">PMC7670391</ArticleId><ArticleId IdType="pubmed">33196760</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255&#x2010;2273. doi:10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller E, Brandi G, Winklhofer S, et al. Large and small cerebral vessel involvement in severe COVID&#x2010;19: detailed clinical workup of a Case Series. Stroke. 2020;51:3719&#x2010;3722. doi:10.1161/STROKEAHA.120.031224</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031224</ArticleId><ArticleId IdType="pmc">PMC7678671</ArticleId><ArticleId IdType="pubmed">33054673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail II, Abdelnabi EA, Al&#x2010;Hashel JY, Alroughani R, Ahmed SF. Neuralgic amyotrophy associated with COVID&#x2010;19 infection: a case report and review of the literature. Neurol Sci. 2021;42(6):2161&#x2010;2165. doi:10.1007/s10072-021-05197-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05197-z</ArticleId><ArticleId IdType="pmc">PMC7980790</ArticleId><ArticleId IdType="pubmed">33745038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitry MA, Collins LK, Kazam JJ, Kaicker S, Kovanlikaya A. Parsonage&#x2010;turner syndrome associated with SARS&#x2010;CoV2 (COVID&#x2010;19) infection. Clin Imaging. 2021;72:8&#x2010;10. doi:10.1016/j.clinimag.2020.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC7654330</ArticleId><ArticleId IdType="pubmed">33190028</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacciavillani M, Salvalaggio A, Briani C. Pure sensory neuralgic amyotrophy in COVID&#x2010;19 infection. Muscle Nerve. 2021;63:E7&#x2010;E8. doi:10.1002/mus.27083</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27083</ArticleId><ArticleId IdType="pmc">PMC7537415</ArticleId><ArticleId IdType="pubmed">33001471</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepmann T, Kitzler HH, Lueck C, Platzek I, Reichmann H, Barlinn K. Neuralgic amyotrophy following infection with SARS&#x2010;CoV&#x2010;2. Muscle Nerve. 2020;62:E68&#x2010;E70. doi:10.1002/mus.27035</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27035</ArticleId><ArticleId IdType="pubmed">32710672</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilmot A, Maldonado Slootjes S, Sellimi A, et al. Immune&#x2010;mediated neurological syndromes in SARS&#x2010;CoV&#x2010;2&#x2010;infected patients. J Neurol. 2021;268:751&#x2010;757. doi:10.1007/s00415-020-10108-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10108-x</ArticleId><ArticleId IdType="pmc">PMC7391231</ArticleId><ArticleId IdType="pubmed">32734353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J, Reincke SM, Pruss H. Do cross&#x2010;reactive antibodies cause neuropathology in COVID&#x2010;19? Nat Rev Immunol. 2020;20:645&#x2010;646. doi:10.1038/s41577-020-00458-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00458-y</ArticleId><ArticleId IdType="pmc">PMC7537977</ArticleId><ArticleId IdType="pubmed">33024283</ArticleId></ArticleIdList></Reference><Reference><Citation>Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID&#x2010;19 and Guillain&#x2010;Barre syndrome. Brain. 2021;144:682&#x2010;693. doi:10.1093/brain/awaa433</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa433</ArticleId><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschoff R, Zimmermann N, Beissert S, Gunther C. Type I interferon signature in Chilblain&#x2010;like lesions associated with the COVID&#x2010;19 pandemic. Dermatopathology (Basel). 2020;7:57&#x2010;63. doi:10.3390/dermatopathology7030010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/dermatopathology7030010</ArticleId><ArticleId IdType="pmc">PMC7768511</ArticleId><ArticleId IdType="pubmed">33291622</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID&#x2010;19: a retrospective cohort study. Lancet Haematol. 2020;7:e671&#x2010;e678. doi:10.1016/S2352-3026(20)30217-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30217-9</ArticleId><ArticleId IdType="pmc">PMC7351397</ArticleId><ArticleId IdType="pubmed">32659214</ArticleId></ArticleIdList></Reference><Reference><Citation>Helbok R, Beer R, L&#xf6;scher W, et al. Guillain&#x2010;Barre syndrome in a patient with antibodies against SARS&#x2010;COV&#x2010;2. Eur J Neurol. 2020;27:1754&#x2010;1756. doi:10.1111/ene.14388</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14388</ArticleId><ArticleId IdType="pmc">PMC7323168</ArticleId><ArticleId IdType="pubmed">32531083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain&#x2010;Barre syndrome associated with SARS&#x2010;CoV&#x2010;2 infection: causality or coincidence? Lancet Neurol. 2020;19:383&#x2010;384. doi:10.1016/S1474-4422(20)30109-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaud S, Budowski C, Tin SNW, Degos B. Post SARS&#x2010;CoV&#x2010;2 Guillain&#x2010;Barre syndrome. Clin Neurophysiol. 2020;131(7):1652&#x2010;1654. doi:10.1016/j.clinph.2020.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7212990</ArticleId><ArticleId IdType="pubmed">32422529</ArticleId></ArticleIdList></Reference><Reference><Citation>Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho&#x2010;Nevers E. COVID&#x2010;19 may induce Guillain&#x2010;Barre syndrome. Rev Neurol (Paris). 2020;176:516&#x2010;518. doi:10.1016/j.neurol.2020.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7158797</ArticleId><ArticleId IdType="pubmed">32334841</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheidl E, Canseco DD, Hadji&#x2010;Naumov A, Bereznai B. Guillain&#x2010;Barre syndrome during SARS&#x2010;CoV&#x2010;2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst. 2020;25:204&#x2010;207. doi:10.1111/jns.12382</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12382</ArticleId><ArticleId IdType="pmc">PMC7273104</ArticleId><ArticleId IdType="pubmed">32388880</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzi MA, Ayromlou H, Jahanbakhsh N, Bavil PH, Janzadeh A, Shayan FK. Guillain&#x2010;Barre syndrome in a patient infected with SARS&#x2010;CoV&#x2010;2, a case report. J Neuroimmunol. 2020;346:577294. doi:10.1016/j.jneuroim.2020.577294</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2020.577294</ArticleId><ArticleId IdType="pmc">PMC7305747</ArticleId><ArticleId IdType="pubmed">32590125</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti P, Beretta S, Piatti M, et al. Guillain&#x2010;Barre syndrome related to COVID&#x2010;19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e741. doi:10.1212/NXI.0000000000000741</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000741</ArticleId><ArticleId IdType="pmc">PMC7217652</ArticleId><ArticleId IdType="pubmed">32350026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottaviani D, Boso F, Tranquillini E, et al. Early Guillain&#x2010;Barre syndrome in coronavirus disease 2019 (COVID&#x2010;19): a case report from an Italian COVID&#x2010;hospital. Neurol Sci. 2020;41:1351&#x2010;1354. doi:10.1007/s10072-020-04449-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04449-8</ArticleId><ArticleId IdType="pmc">PMC7216127</ArticleId><ArticleId IdType="pubmed">32399950</ArticleId></ArticleIdList></Reference><Reference><Citation>Padroni M, Mastrangelo V, Asioli GM, et al. Guillain&#x2010;Barre syndrome following COVID&#x2010;19: new infection, old complication? J Neurol. 2020;267:1877&#x2010;1879. doi:10.1007/s00415-020-09849-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09849-6</ArticleId><ArticleId IdType="pmc">PMC7180646</ArticleId><ArticleId IdType="pubmed">32333166</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N, Russo T, Falzone YM, et al. Post&#x2010;infectious Guillain&#x2010;Barre syndrome related to SARS&#x2010;CoV&#x2010;2 infection: a case report. J Neurol. 2020;267:2492&#x2010;2494. doi:10.1007/s00415-020-09907-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09907-z</ArticleId><ArticleId IdType="pmc">PMC7249981</ArticleId><ArticleId IdType="pubmed">32458192</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayos Galan A, Del Saz Saucedo P, Peinado Postigo F, Botia Paniagua E. Guillain&#x2010;Barre syndrome associated with SARS&#x2010;CoV&#x2010;2 infection. Neurologia. 2020;35:268&#x2010;269. doi:10.1016/j.nrl.2020.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7177091</ArticleId><ArticleId IdType="pubmed">32364123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho&#x2010;Salda&#xf1;a A, Lambea&#x2010;Gil &#xc1;, Liesa JLC, et al. Guillain&#x2010;Barre syndrome associated with leptomeningeal enhancement following SARS&#x2010;CoV&#x2010;2 infection. Clin Med (Lond). 2020;20:e93&#x2010;e94. doi:10.7861/clinmed.2020-0213</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0213</ArticleId><ArticleId IdType="pmc">PMC7385766</ArticleId><ArticleId IdType="pubmed">32518103</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban Molina A, Mata Martinez M, Sanchez Chueca P, Carrillo Lopez A. SARS&#x2010;CoV&#x2010;2, A new causative agent of Guillain&#x2010;Barre syndrome? Med Intensiva. 2022;46(2):110&#x2010;111. doi:10.1016/j.medin.2020.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2020.08.009</ArticleId><ArticleId IdType="pmc">PMC8612816</ArticleId><ArticleId IdType="pubmed">34887232</ArticleId></ArticleIdList></Reference><Reference><Citation>Su XW, Palka SV, Rao RR, Chen FS, Brackney CR, Cambi F. SARS&#x2010;CoV&#x2010;2&#x2010;associated Guillain&#x2010;Barre syndrome with dysautonomia. Muscle Nerve. 2020;62:E48&#x2010;E49. doi:10.1002/mus.26988</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26988</ArticleId><ArticleId IdType="pmc">PMC7283744</ArticleId><ArticleId IdType="pubmed">32445201</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb S, Wallace VC, Martin&#x2010;Lopez D, Yogarajah M. Guillain&#x2010;Barre syndrome following COVID&#x2010;19: a newly emerging post&#x2010;infectious complication. BMJ Case Rep. 2020;13(6):e236182. doi:10.1136/bcr-2020-236182</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236182</ArticleId><ArticleId IdType="pmc">PMC10577730</ArticleId><ArticleId IdType="pubmed">32540883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiet MY, AlShaikh N. Guillain&#x2010;Barre syndrome associated with COVID&#x2010;19 infection: a case from the UK. BMJ Case Rep. 2020;13(7):e236536. doi:10.1136/bcr-2020-236536</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236536</ArticleId><ArticleId IdType="pmc">PMC7348325</ArticleId><ArticleId IdType="pubmed">32641309</ArticleId></ArticleIdList></Reference><Reference><Citation>Coen M, Jeanson G, Culebras Almeida LA, et al. Guillain&#x2010;Barre syndrome as a complication of SARS&#x2010;CoV&#x2010;2 infection. Brain Behav Immun. 2020;87:111&#x2010;112. doi:10.1016/j.bbi.2020.04.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.074</ArticleId><ArticleId IdType="pmc">PMC7194931</ArticleId><ArticleId IdType="pubmed">32360440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigli GL, Bax F, Marini A, et al. Guillain&#x2010;Barre syndrome in the COVID&#x2010;19 era: just an occasional cluster? J Neurol. 2021;268(4):1195&#x2010;1197. doi:10.1007/s00415-020-09911-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09911-3</ArticleId><ArticleId IdType="pmc">PMC7236438</ArticleId><ArticleId IdType="pubmed">32430572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale A, Sabaretnam S, Lewinsohn A. Guillain&#x2010;Barre syndrome and COVID&#x2010;19: association or coincidence. BMJ Case Rep. 2020;13(11):e239241. doi:10.1136/bcr-2020-239241</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239241</ArticleId><ArticleId IdType="pmc">PMC7705579</ArticleId><ArticleId IdType="pubmed">33257396</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifa M, Zakaria F, Ragab Y, et al. Guillain&#x2010;Barre syndrome associated with severe acute respiratory syndrome coronavirus 2 detection and coronavirus disease 2019 in a child. J Pediatric Infect Dis Soc. 2020;9:510&#x2010;513. doi:10.1093/jpids/piaa086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa086</ArticleId><ArticleId IdType="pmc">PMC7454732</ArticleId><ArticleId IdType="pubmed">32652520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigaut K, Mallaret M, Baloglu S, et al. Guillain&#x2010;Barre syndrome related to SARS&#x2010;CoV&#x2010;2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e785. doi:10.1212/NXI.0000000000000785</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000785</ArticleId><ArticleId IdType="pmc">PMC7286648</ArticleId><ArticleId IdType="pubmed">32461235</ArticleId></ArticleIdList></Reference><Reference><Citation>Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID&#x2010;19 related Guillain&#x2010;Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020;41:1657&#x2010;1658. doi:10.1007/s10072-020-04484-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04484-5</ArticleId><ArticleId IdType="pmc">PMC8849645</ArticleId><ArticleId IdType="pubmed">32468450</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz&#x2010;Akarsu E, Ozpar R, Mirzayev H, et al. Guillain&#x2010;Barre syndrome in a patient with minimal symptoms of COVID&#x2010;19 infection. Muscle Nerve. 2020;62:E54&#x2010;E57. doi:10.1002/mus.26992</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26992</ArticleId><ArticleId IdType="pmc">PMC7300697</ArticleId><ArticleId IdType="pubmed">32497292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JL, Ebadi H, Sarna JR. Guillain&#x2010;Barre syndrome with facial diplegia related to SARS&#x2010;CoV&#x2010;2 infection. Can J Neurol Sci. 2020;47:852&#x2010;854. doi:10.1017/cjn.2020.106</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.106</ArticleId><ArticleId IdType="pmc">PMC7308598</ArticleId><ArticleId IdType="pubmed">32468972</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosti E, Giorgianni A, D'Amore F, Vinacci G, Balbi S, Locatelli D. Is Guillain&#x2010;Barre syndrome triggered by SARS&#x2010;CoV&#x2010;2? Case report and literature review. Neurol Sci. 2021;42(2):607&#x2010;612. doi:10.1007/s10072-020-04553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04553-9</ArticleId><ArticleId IdType="pmc">PMC7343406</ArticleId><ArticleId IdType="pubmed">32643136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilinc D, Pasch S, Doets AY, Jacobs BC, Vliet J, Garssen MPJ. Guillain&#x2010;Barre syndrome after SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2020;27:1757&#x2010;1758. doi:10.1111/ene.14398</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14398</ArticleId><ArticleId IdType="pmc">PMC7323246</ArticleId><ArticleId IdType="pubmed">32533876</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Manzanedo S, Lopez de la Oliva Calvo L, Ruiz Alvarez L. Guillain&#x2010;Barre syndrome after Covid&#x2010;19 infection. Med Clin (Engl Ed). 2020;155:366. doi:10.1016/j.medcle.2020.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcle.2020.06.019</ArticleId><ArticleId IdType="pmc">PMC7526591</ArticleId><ArticleId IdType="pubmed">33020737</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes&#x2010;Bueno JA, Garc&#xed;a&#x2010;Trujillo L, Urbaneja P, et al. Miller&#x2010;Fisher syndrome after SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2020;27:1759&#x2010;1761. doi:10.1111/ene.14383</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14383</ArticleId><ArticleId IdType="pmc">PMC7300794</ArticleId><ArticleId IdType="pubmed">32503084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracaglia M, Naldi I, Govoni A, Brillanti Ventura D, De Massis P. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS&#x2010;CoV&#x2010;2. J Neurol. 2020;267:3166&#x2010;3168. doi:10.1007/s00415-020-10014-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10014-2</ArticleId><ArticleId IdType="pmc">PMC7315403</ArticleId><ArticleId IdType="pubmed">32588185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossein Mozhdehipanah SP, Gorji R. Guillain&#x2013;Barr&#xe9; syndrome as a neurological complication of COVID&#x2010;19 infection: A case series and review of the literature. Int Clin Neurosci J. 2020;7:156&#x2010;161. doi:10.34172/icnj.2020.18</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/icnj.2020.18</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimzadeh SA, Rahimian AGN. Guillain&#x2010;Barr&#xe9; syndrome associated with the coronavirus disease 2019 (COVID&#x2010;19). Neurology Clin Pract. 2021;11(2):e196&#x2010;e198. doi:10.1212/CPJ.0000000000000879</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000879</ArticleId><ArticleId IdType="pmc">PMC8032427</ArticleId><ArticleId IdType="pubmed">33842092</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano, G , Palmerini F, Ravaglia S, et al. Guillain&#x2010;Barre Syndrome Associated with SARS&#x2010;CoV&#x2010;2. N Engl J Med. 2020;382:2574&#x2010;2576, doi:10.1056/NEJMc2009191</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P, Bellavita G, D'Acunto L, et al. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain&#x2010;Barre syndrome and polyneuritis cranialis in COVID&#x2010;19 patients: A case series. J Med Virol. 2021;93:766&#x2010;774. doi:10.1002/jmv.26289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26289</ArticleId><ArticleId IdType="pmc">PMC7405169</ArticleId><ArticleId IdType="pubmed">32662899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampe A, Winschel A, Lang C, Steiner T. Guillain&#x2010;Barre syndrome and SARS&#x2010;CoV&#x2010;2. Neurol Res Pract. 2020;2:19. doi:10.1186/s42466-020-00066-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-020-00066-0</ArticleId><ArticleId IdType="pmc">PMC7340740</ArticleId><ArticleId IdType="pubmed">32835165</ArticleId></ArticleIdList></Reference><Reference><Citation>Naddaf E, Laughlin RS, Klein CJ, et al. Guillain&#x2010;Barre syndrome in a patient with evidence of recent SARS&#x2010;CoV&#x2010;2 infection. Mayo Clin Proc. 2020;95:1799&#x2010;1801. doi:10.1016/j.mayocp.2020.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.029</ArticleId><ArticleId IdType="pmc">PMC7284228</ArticleId><ArticleId IdType="pubmed">32753154</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID&#x2010;19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2010;3120. doi:10.1093/brain/awaa240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferkorn T, Dabitz R, von Wernitz&#x2010;Keibel T, Aufenanger J, Nowak&#x2010;Machen M, Janssen H. Acute polyradiculoneuritis with locked&#x2010;in syndrome in a patient with Covid&#x2010;19. J Neurol. 2020;267:1883&#x2010;1884. doi:10.1007/s00415-020-09897-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09897-y</ArticleId><ArticleId IdType="pmc">PMC7216124</ArticleId><ArticleId IdType="pubmed">32399694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana S, Lima AA, Chandra R, et al. Novel coronavirus (COVID&#x2010;19)&#x2010;associated Guillain&#x2010;Barre syndrome: case report. J Clin Neuromuscul Dis. 2020;21:240&#x2010;242. doi:10.1097/CND.0000000000000309</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0000000000000309</ArticleId><ArticleId IdType="pmc">PMC7273962</ArticleId><ArticleId IdType="pubmed">32453100</ArticleId></ArticleIdList></Reference><Reference><Citation>Amira Sidig, K. A , Abbasher Hussien, Abbasher Mohammed, Hussien Abbasher. COVID&#x2010;19 and Guillain&#x2010;Barre syndrome case report. doi:10.21203/rs.3.rs-48327/v1 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-48327/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lascano AM, Epiney JB, Coen M, et al. SARS&#x2010;CoV&#x2010;2 and Guillain&#x2010;Barre syndrome: AIDP variant with a favourable outcome. Eur J Neurol. 2020;27:1751&#x2010;1753. doi:10.1111/ene.14368</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14368</ArticleId><ArticleId IdType="pmc">PMC7300656</ArticleId><ArticleId IdType="pubmed">32478936</ArticleId></ArticleIdList></Reference><Reference><Citation>el Otmani H, el Moutawakil B, Rafai MA, et al. Covid&#x2010;19 and Guillain&#x2010;Barre syndrome: more than a coincidence! Rev Neurol (Paris). 2020;176:518&#x2010;519. doi:10.1016/j.neurol.2020.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7180370</ArticleId><ArticleId IdType="pubmed">32359804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID&#x2010;19 infection: A case report. J Clin Neurosci. 2020;76:233&#x2010;235. doi:10.1016/j.jocn.2020.04.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId><ArticleId IdType="pmc">PMC7158817</ArticleId><ArticleId IdType="pubmed">32312628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zito A, Alfonsi E, Franciotta D, et al. COVID&#x2010;19 and Guillain&#x2010;Barre syndrome: a case report and review of literature. Front Neurol. 2020;11:909. doi:10.3389/fneur.2020.00909</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00909</ArticleId><ArticleId IdType="pmc">PMC7471770</ArticleId><ArticleId IdType="pubmed">32973665</ArticleId></ArticleIdList></Reference><Reference><Citation>Abolmaali M, Heidari M, Zeinali M, et al. Guillain&#x2010;Barre syndrome as a parainfectious manifestation of SARS&#x2010;CoV&#x2010;2 infection: A case series. J Clin Neurosci. 2021;83:119&#x2010;122. doi:10.1016/j.jocn.2020.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.11.013</ArticleId><ArticleId IdType="pmc">PMC7666532</ArticleId><ArticleId IdType="pubmed">33281050</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank CHM, Almeida TVR, Marques EA, et al. Guillain&#x2010;Barre syndrome associated with SARS&#x2010;CoV&#x2010;2 infection in a pediatric patient. J Trop Pediatr. 2021;67(3):fmaa044. doi:10.1093/tropej/fmaa044</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmaa044</ArticleId><ArticleId IdType="pmc">PMC7529009</ArticleId><ArticleId IdType="pubmed">32653906</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrelli C, Scendoni R, Paglioriti M, Logullo FO. Acute motor axonal neuropathy related to COVID&#x2010;19 infection: a new diagnostic overview. J Clin Neuromuscul Dis. 2020;22:120&#x2010;121. doi:10.1097/CND.0000000000000322</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0000000000000322</ArticleId><ArticleId IdType="pmc">PMC7678351</ArticleId><ArticleId IdType="pubmed">33214404</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA, Ghosh R. COVID&#x2010;19 polyradiculitis in 24 patients without SARS&#x2010;CoV&#x2010;2 in the cerebro&#x2010;spinal fluid. J Med Virol. 2021;93:66&#x2010;68. doi:10.1002/jmv.26121</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26121</ArticleId><ArticleId IdType="pmc">PMC7300798</ArticleId><ArticleId IdType="pubmed">32497288</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins KL, Jansen JH, Comer AD, et al. COVID&#x2010;19&#x2010;associated bifacial weakness with paresthesia subtype of Guillain&#x2010;Barre syndrome. AJNR Am J Neuroradiol. 2020;41:1707&#x2010;1711. doi:10.3174/ajnr.A6654</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6654</ArticleId><ArticleId IdType="pmc">PMC7583115</ArticleId><ArticleId IdType="pubmed">32586958</ArticleId></ArticleIdList></Reference><Reference><Citation>Tard C, Maurage CA, de Paula AM, et al. Anti&#x2010;pan&#x2010;neurofascin IgM in COVID&#x2010;19&#x2010;related Guillain&#x2010;Barre syndrome: evidence for a nodo&#x2010;paranodopathy. Neurophysiol Clin. 2020;50:397&#x2010;399. doi:10.1016/j.neucli.2020.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2020.09.007</ArticleId><ArticleId IdType="pmc">PMC7543699</ArticleId><ArticleId IdType="pubmed">33190687</ArticleId></ArticleIdList></Reference><Reference><Citation>Paybast S, Gorji R, Mavandadi S. Guillain&#x2010;Barre syndrome as a neurological complication of novel COVID&#x2010;19 infection: a case report and review of the literature. Neurologist. 2020;25:101&#x2010;103. doi:10.1097/NRL.0000000000000291</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NRL.0000000000000291</ArticleId><ArticleId IdType="pmc">PMC7363390</ArticleId><ArticleId IdType="pubmed">32618839</ArticleId></ArticleIdList></Reference><Reference><Citation>Marta&#x2010;Enguita J, Rubio&#x2010;Baines I, Gaston&#x2010;Zubimendi I. Fatal Guillain&#x2010;Barre syndrome after infection with SARS&#x2010;CoV&#x2010;2. Neurologia. 2020;35:265&#x2010;267. doi:10.1016/j.nrl.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7166023</ArticleId><ArticleId IdType="pubmed">32364124</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani A, Rabold E, Hanson T, et al. Guillain&#x2010;Barre syndrome associated with SARS&#x2010;CoV&#x2010;2 infection. IDCases. 2020;20:e00771. doi:10.1016/j.idcr.2020.e00771</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00771</ArticleId><ArticleId IdType="pmc">PMC7165113</ArticleId><ArticleId IdType="pubmed">32313807</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Kim BD, Markantone DM, et al. Severe rapidly progressive Guillain&#x2010;Barre syndrome in the setting of acute COVID&#x2010;19 disease. J Neurovirol. 2020;26:797&#x2010;799. doi:10.1007/s13365-020-00884-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00884-7</ArticleId><ArticleId IdType="pmc">PMC7384559</ArticleId><ArticleId IdType="pubmed">32720233</ArticleId></ArticleIdList></Reference><Reference><Citation>Faqihi F, Alharthy A, Memish ZA, Kutsogiannis DJ, Brindley PG, Karakitsos D. Peripheral neuropathy in severe COVID&#x2010;19 resolved with therapeutic plasma exchange. Clin Case Rep. 2020;8(12):3234&#x2010;3239. doi:10.1002/ccr3.3397</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3397</ArticleId><ArticleId IdType="pmc">PMC7675564</ArticleId><ArticleId IdType="pubmed">33230414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lantos JE, Strauss SB, Lin E. COVID&#x2010;19&#x2010;associated Miller Fisher syndrome: MRI findings. AJNR Am J Neuroradiol. 2020;41:1184&#x2010;1186. doi:10.3174/ajnr.A6609</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6609</ArticleId><ArticleId IdType="pmc">PMC7357656</ArticleId><ArticleId IdType="pubmed">32467190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez&#x2010;Dominguez J, Ameijide&#x2010;Sanluis E, Garcia&#x2010;Cabo C, Garcia&#x2010;Rodriguez R, Mateos V. Miller&#x2010;Fisher&#x2010;like syndrome related to SARS&#x2010;CoV&#x2010;2 infection (COVID 19). J Neurol. 2020;267:2495&#x2010;2496. doi:10.1007/s00415-020-09912-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09912-2</ArticleId><ArticleId IdType="pmc">PMC7249969</ArticleId><ArticleId IdType="pubmed">32458195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan MSCH, Kelly S, Tamimi M, Giglio BAL. A case series of Guillain&#x2010;Barr&#xe9; syndrome following Covid&#x2010;19 infection in New York. Neurol Clin Pract. 2020;11(4):e576&#x2010;e578. doi:10.1212/CPJ.0000000000000880</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000880</ArticleId><ArticleId IdType="pmc">PMC8382418</ArticleId><ArticleId IdType="pubmed">34484964</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez&#x2010;Ortiz C, M&#xe9;ndez&#x2010;Guerrero A, Rodrigo&#x2010;Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID&#x2010;19. Neurology. 2020;95:e601&#x2010;e605. doi:10.1212/WNL.0000000000009619</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009619</ArticleId><ArticleId IdType="pubmed">32303650</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P, Pesavento V, Buoite Stella A, et al. Miller Fisher syndrome diagnosis and treatment in a patient with SARS&#x2010;CoV&#x2010;2. J Neurovirol. 2020;26:605&#x2010;606. doi:10.1007/s13365-020-00858-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00858-9</ArticleId><ArticleId IdType="pmc">PMC7288617</ArticleId><ArticleId IdType="pubmed">32529516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufour C, Co TK, Liu A. GM1 ganglioside antibody and COVID&#x2010;19 related Guillain Barre syndrome&#x2014;case report, systemic review and implication for vaccine development. Brain Behav Immun Health. 2021;12:100203. doi:10.1016/j.bbih.2021.100203</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100203</ArticleId><ArticleId IdType="pmc">PMC7805391</ArticleId><ArticleId IdType="pubmed">33462567</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkin M, Gao V, Kahan J, et al. COVID&#x2010;19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020;95:221&#x2010;223. doi:10.1212/WNL.0000000000009700</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009700</ArticleId><ArticleId IdType="pubmed">32358218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R, Roy D, Sengupta S, Benito&#x2010;Leon J. Autonomic dysfunction heralding acute motor axonal neuropathy in COVID&#x2010;19. J Neurovirol. 2020;26:964&#x2010;966. doi:10.1007/s13365-020-00908-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00908-2</ArticleId><ArticleId IdType="pmc">PMC7485423</ArticleId><ArticleId IdType="pubmed">32918164</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Shiza ST, Saadat R, Dawe M, Rehman U. Association of Guillain&#x2010;Barre syndrome with COVID&#x2010;19: a case report and literature review. Cureus. 2021;13:e13828. doi:10.7759/cureus.13828</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13828</ArticleId><ArticleId IdType="pmc">PMC8035985</ArticleId><ArticleId IdType="pubmed">33854850</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosto M, Cotti Piccinelli S, Gazzina S, et al. Guillain&#x2010;Barre syndrome and COVID&#x2010;19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92(7):751&#x2010;756. doi:10.1136/jnnp-2020-324837</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324837</ArticleId><ArticleId IdType="pubmed">33158914</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragiel M, Mir&#xf3; &#xd2;, Llorens P, et al. Incidence, clinical, risk factors and outcomes of Guillain&#x2010;Barre in Covid&#x2010;19. Ann Neurol. 2021;89:598&#x2010;603. doi:10.1002/ana.25987</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25987</ArticleId><ArticleId IdType="pubmed">33295021</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra B, Lizarazo J, Jim&#xe9;nez&#x2010;Arango JA, et al. Guillain&#x2010;Barre syndrome associated with Zika Virus infection in Colombia. N Engl J Med. 2016;375:1513&#x2010;1523. doi:10.1056/NEJMoa1605564</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1605564</ArticleId><ArticleId IdType="pubmed">27705091</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain&#x2010;Barre syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32:150&#x2010;163. doi:10.1159/000184748</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000184748</ArticleId><ArticleId IdType="pubmed">19088488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki N, Hartung HP. Guillain&#x2010;Barre syndrome. N Engl J Med. 2012;366:2294&#x2010;2304. doi:10.1056/NEJMra1114525</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1114525</ArticleId><ArticleId IdType="pubmed">22694000</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain&#x2010;Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469&#x2010;482. doi:10.1038/nrneurol.2014.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.121</ArticleId><ArticleId IdType="pubmed">25023340</ArticleId></ArticleIdList></Reference><Reference><Citation>Willison HJ, Jacobs BC, van Doorn PA. Guillain&#x2010;Barre syndrome. Lancet. 2016;388:717&#x2010;727. doi:10.1016/S0140-6736(16)00339-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00339-1</ArticleId><ArticleId IdType="pubmed">26948435</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti MD, Pugliatti M, D'Alessandro R, et al. A multicentric prospective incidence study of Guillain&#x2010;Barre syndrome in Italy. The ITANG study. Neuroepidemiology. 2015;45:90&#x2010;99. doi:10.1159/000438752</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000438752</ArticleId><ArticleId IdType="pubmed">26329724</ArticleId></ArticleIdList></Reference><Reference><Citation>Uncini A, Foresti C, Frigeni B, et al. Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS&#x2010;CoV&#x2010;2 infection. Neurophysiol Clin. 2021;51:183&#x2010;191. doi:10.1016/j.neucli.2021.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC7891083</ArticleId><ArticleId IdType="pubmed">33685769</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez&#x2010;Suarez I, Sanz&#x2010;Gallego I, Rodriguez de Rivera FJ, Arpa J. Guillain&#x2010;Barre syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol. 2013;13:95. doi:10.1186/1471-2377-13-95</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-95</ArticleId><ArticleId IdType="pmc">PMC3723666</ArticleId><ArticleId IdType="pubmed">23876199</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi T, Er B, Koh JS, Goh YH, Chua L. Guillain&#x2010;Barre syndrome decreases in Singapore during the COVID&#x2010;19 pandemic. J Peripher Nerv Syst. 2021;26(2):235&#x2010;236. doi:10.1111/jns.12439</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12439</ArticleId><ArticleId IdType="pmc">PMC8251005</ArticleId><ArticleId IdType="pubmed">33713512</ArticleId></ArticleIdList></Reference><Reference><Citation>Luijten LWG, Leonhard SE, van der Eijk A, et al. Guillain&#x2010;Barre syndrome after SARS&#x2010;CoV&#x2010;2 infection in an international prospective cohort study. Brain. 2021;144:3392&#x2010;3404. doi:10.1093/brain/awab279</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab279</ArticleId><ArticleId IdType="pmc">PMC8677532</ArticleId><ArticleId IdType="pubmed">34553216</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CW, Syue LS, Tsai YS, et al. Anosmia and olfactory tract neuropathy in a case of COVID&#x2010;19. J Microbiol Immunol Infect. 2021;54:93&#x2010;96. doi:10.1016/j.jmii.2020.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7305498</ArticleId><ArticleId IdType="pubmed">32576457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D, Imbach LL, Ulrich S, et al. Inflammatory olfactory neuropathy in two patients with COVID&#x2010;19. Lancet. 2020;396:166. doi:10.1016/S0140-6736(20)31525-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31525-7</ArticleId><ArticleId IdType="pmc">PMC7351381</ArticleId><ArticleId IdType="pubmed">32659210</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo&#x2010;Armenteros P, Uterga&#x2010;Valiente JM, Zabala&#x2010;del&#x2010;Arco J, et al. Optic neuropathy in a patient with COVID&#x2010;19 infection. Acta Neurol Belg. 2021;1&#x2010;3. doi:10.1007/s13760-021-01600-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01600-w</ArticleId><ArticleId IdType="pmc">PMC7852464</ArticleId><ArticleId IdType="pubmed">33528821</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois J, Collery AS, Hayek G, et al. Coronavirus disease 2019&#x2010;associated ocular neuropathy with panuveitis: a case report. JAMA Ophthalmol. 2021;139:247&#x2010;249. doi:10.1001/jamaophthalmol.2020.5695</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2020.5695</ArticleId><ArticleId IdType="pubmed">33331870</ArticleId></ArticleIdList></Reference><Reference><Citation>Belghmaidi S, Nassih H, Boutgayout S, et al. Third cranial nerve palsy presenting with unilateral diplopia and strabismus in a 24&#x2010;year&#x2010;old woman with COVID&#x2010;19. Am J Case Rep. 2020;21:e925897. doi:10.12659/AJCR.925897</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.925897</ArticleId><ArticleId IdType="pmc">PMC7571280</ArticleId><ArticleId IdType="pubmed">33056942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H, Yin H, Huang M, Guo Z. The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020;267:1550&#x2010;1553. doi:10.1007/s00415-020-09773-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09773-9</ArticleId><ArticleId IdType="pmc">PMC7087661</ArticleId><ArticleId IdType="pubmed">32100124</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma Y, Watanabe M, Inoue K, Moritaka T. Coronavirus disease&#x2010;19 pneumonia with facial nerve palsy and olfactory disturbance. Intern Med. 2020;59:1773&#x2010;1775. doi:10.2169/internalmedicine.5014-20</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.5014-20</ArticleId><ArticleId IdType="pmc">PMC7434541</ArticleId><ArticleId IdType="pubmed">32669517</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl EH, Mosevoll KA, Cramariuc D, Vedeler CA, Blomberg B. COVID&#x2010;19 myocarditis and postinfection Bell's palsy. BMJ Case Rep. 2021;14(1):e240095. doi:10.1136/bcr-2020-240095</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-240095</ArticleId><ArticleId IdType="pmc">PMC7802700</ArticleId><ArticleId IdType="pubmed">33431479</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh Y, Beh DLL, Makmur A, Somani J, Chan ACY. Pearls &amp; Oy&#x2010;sters: Facial nerve palsy in COVID&#x2010;19 infection. Neurology. 2020;95:364&#x2010;367. doi:10.1212/WNL.0000000000009863</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009863</ArticleId><ArticleId IdType="pubmed">32439822</ArticleId></ArticleIdList></Reference><Reference><Citation>Derollez C, Alberto T, Leroi I, Mackowiak MA, Chen Y. Facial nerve palsy: an atypical clinical manifestation of COVID&#x2010;19 infection in a family cluster. Eur J Neurol. 2020;27:2670&#x2010;2672. doi:10.1111/ene.14493</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14493</ArticleId><ArticleId IdType="pmc">PMC7461229</ArticleId><ArticleId IdType="pubmed">32853484</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima MA, Silva MTT, Soares CN, et al. Peripheral facial nerve palsy associated with COVID&#x2010;19. J Neurovirol. 2020;26:941&#x2010;944. doi:10.1007/s13365-020-00912-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00912-6</ArticleId><ArticleId IdType="pmc">PMC7531061</ArticleId><ArticleId IdType="pubmed">33006717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastola A, Sah R, Nepal G, et al. Bell's palsy as a possible neurological complication of COVID&#x2010;19: A case report. Clin Case Rep. 2021;9:747&#x2010;750. doi:10.1002/ccr3.3631</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3631</ArticleId><ArticleId IdType="pmc">PMC7869308</ArticleId><ArticleId IdType="pubmed">33598238</ArticleId></ArticleIdList></Reference><Reference><Citation>Neo WL, Ng JCF, Iyer NG. The great pretender&#x2010;Bell's palsy secondary to SARS&#x2010;CoV&#x2010;2? Clin Case Rep. 2021;9:1175&#x2010;1177. doi:10.1002/ccr3.3716</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.3716</ArticleId><ArticleId IdType="pmc">PMC7981606</ArticleId><ArticleId IdType="pubmed">33768805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Narayanan P, Shetty S, Mohammed AP. Lower motor neuron facial palsy in a postnatal mother with COVID&#x2010;19. BMJ Case Rep. 2021;14(3):e240267. doi:10.1136/bcr-2020-240267</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-240267</ArticleId><ArticleId IdType="pmc">PMC7929834</ArticleId><ArticleId IdType="pubmed">33649026</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Muras A, Carmona&#x2010;Abell&#xe1;n MM, Coll&#xed;a Fern&#xe1;ndez A, Uterga Valiente JM, Ant&#xf3;n M&#xe9;ndez L, Garc&#xed;a&#x2010;Monc&#xf3; JC. Bilateral facial nerve palsy associated with COVID&#x2010;19 and Epstein&#x2010;Barr virus co&#x2010;infection. Eur J Neurol. 2021;28:358&#x2010;360. doi:10.1111/ene.14561</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14561</ArticleId><ArticleId IdType="pmc">PMC7537085</ArticleId><ArticleId IdType="pubmed">32997868</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaja M, Gomez GPR, Santana Y, et al. A 44&#x2010;year&#x2010;old Hispanic man with loss of taste and bilateral facial weakness diagnosed with Guillain&#x2010;Barre syndrome and Bell's Palsy associated with SARS&#x2010;CoV&#x2010;2 infection treated with intravenous immunoglobulin. Am J Case Rep. 2020;21:e927956. doi:10.12659/AJCR.927956</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.927956</ArticleId><ArticleId IdType="pmc">PMC7643409</ArticleId><ArticleId IdType="pubmed">33128540</ArticleId></ArticleIdList></Reference><Reference><Citation>Juliao Caamano DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain&#x2010;Barre syndrome as a rare neurological complication of SARS&#x2010;CoV&#x2010;2. J Clin Neurosci. 2020;77:230&#x2010;232. doi:10.1016/j.jocn.2020.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.05.016</ArticleId><ArticleId IdType="pmc">PMC7221378</ArticleId><ArticleId IdType="pubmed">32410788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogia B, Gil Guevara A, Rai PK, Fang X. A case of COVID&#x2010;19 with multiple cranial neuropathies. Int J Neurosci. 2020;1&#x2010;3. doi:10.1080/00207454.2020.1869001</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2020.1869001</ArticleId><ArticleId IdType="pubmed">33372575</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel Rhman S, Abdel Wahid A. COVID&#x2010;19 and sudden sensorineural hearing loss, a case report. Otolaryngology case reports. 2020;16:100198. doi:10.1016/j.xocr.2020.100198</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xocr.2020.100198</ArticleId><ArticleId IdType="pmc">PMC7342036</ArticleId><ArticleId IdType="pubmed">34957357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic O, Kalcioglu MT, Cag Y, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID&#x2010;19? An investigation into SARS&#x2010;COV&#x2010;2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208&#x2010;211. doi:10.1016/j.ijid.2020.06.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.023</ArticleId><ArticleId IdType="pmc">PMC7289736</ArticleId><ArticleId IdType="pubmed">32535294</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen C, Lenarz T, Willenborg K. Acute profound sensorineural hearing loss after COVID&#x2010;19 pneumonia. Mayo Clin Proc. 2020;95:1801&#x2010;1803. doi:10.1016/j.mayocp.2020.05.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.034</ArticleId><ArticleId IdType="pmc">PMC7275185</ArticleId><ArticleId IdType="pubmed">32753155</ArticleId></ArticleIdList></Reference><Reference><Citation>Decavel P, Petit C, Tatu L. Tapia syndrome at the time of the COVID&#x2010;19 pandemic: Lower cranial neuropathy following prolonged intubation. Neurology. 2020;95:312&#x2010;313. doi:10.1212/WNL.0000000000010011</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010011</ArticleId><ArticleId IdType="pubmed">32518147</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gennaro R, Gastaldo E, Tamborino C, et al. Selective cranial multineuritis in severe COVID&#x2010;19 pneumonia: two cases and literature review. Neurol Sci. 2021;42(5):1643&#x2010;1648. doi:10.1007/s10072-021-05087-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05087-4</ArticleId><ArticleId IdType="pmc">PMC7847241</ArticleId><ArticleId IdType="pubmed">33515336</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa Martins, D , Branco Ribeiro, S , Jesus Pereira, I , Mestre, S , Rios, J Unilateral Hypoglossal Nerve Palsy as a COVID&#x2010;19 Sequel. Am J Phys Med Rehab. 2020;99:1096&#x2010;1098, doi:10.1097/PHM.0000000000001607</Citation><ArticleIdList><ArticleId IdType="pubmed">33002915</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer CE, Bhatt JM, Oliveira CA, Dinkin MJ. Isolated Cranial Nerve 6 Palsy in 6 Patients With COVID&#x2010;19 Infection. J Neuroophthalmol. 2020;40:520&#x2010;522. doi:10.1097/WNO.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0000000000001146</ArticleId><ArticleId IdType="pubmed">32941331</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa&#x2010;Estomba CM, de Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild&#x2010;to&#x2010;moderate forms of the coronavirus disease (COVID&#x2010;19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277:2251&#x2010;2261. doi:10.1007/s00405-020-05965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia and ageusia in COVID&#x2010;19 patients: Single&#x2010;center experience on 72 cases. Head Neck. 2020;42:1252&#x2010;1258. doi:10.1002/hed.26204</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26204</ArticleId><ArticleId IdType="pmc">PMC7267244</ArticleId><ArticleId IdType="pubmed">32342566</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID&#x2010;19) and anosmia. JAMA Neurol. 2020;77:1028&#x2010;1029. doi:10.1001/jamaneurol.2020.2125</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2125</ArticleId><ArticleId IdType="pubmed">32469400</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr. Retinal findings in patients with COVID&#x2010;19. Lancet. 2020;395:1610. doi:10.1016/S0140-6736(20)31014-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31014-X</ArticleId><ArticleId IdType="pmc">PMC7217650</ArticleId><ArticleId IdType="pubmed">32405105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira LA, Soares LCM, Nascimento PA, et al. Retinal findings in hospitalised patients with severe COVID&#x2010;19. Br J Ophthalmol. 2022;106(1):102&#x2010;105. doi:10.1136/bjophthalmol-2020-317576</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317576</ArticleId><ArticleId IdType="pubmed">33067361</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporossi T, Bacherini D, Tartaro R, VIrgili G, Peris A, Giansanti F. Retinal findings in patients affected by COVID 19 intubated in an intensive care unit. Acta Ophthalmol. 2021;99:e1244&#x2010;e1245. doi:10.1111/aos.14734</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.14734</ArticleId><ArticleId IdType="pubmed">33377599</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID&#x2010;19: results from the SERPICO&#x2010;19 study. EClinicalMedicine. 2020;27:100550. doi:10.1016/j.eclinm.2020.100550</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100550</ArticleId><ArticleId IdType="pmc">PMC7502280</ArticleId><ArticleId IdType="pubmed">32984785</ArticleId></ArticleIdList></Reference><Reference><Citation>Codeluppi L, Venturelli F, Rossi J, et al. Facial palsy during the COVID&#x2010;19 pandemic. Brain Behav. 2021;11:e01939. doi:10.1002/brb3.1939</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1939</ArticleId><ArticleId IdType="pmc">PMC7821573</ArticleId><ArticleId IdType="pubmed">33159420</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisca G, Garbarino F, Carta S, et al. Increased childhood peripheral facial Palsy in the emergency department during COVID&#x2010;19 pandemic. Pediatr Emerg Care. 2020;36:e595&#x2010;e596. doi:10.1097/PEC.0000000000002231</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PEC.0000000000002231</ArticleId><ArticleId IdType="pubmed">32925698</ArticleId></ArticleIdList></Reference><Reference><Citation>Islamoglu Y, Celik B, Kiris M. Facial paralysis as the only symptom of COVID&#x2010;19: A prospective study. Am J Otolaryngol. 2021;42:102956. doi:10.1016/j.amjoto.2021.102956</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.102956</ArticleId><ArticleId IdType="pmc">PMC7972325</ArticleId><ArticleId IdType="pubmed">33592554</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self&#x2010;reported changes in hearing and tinnitus in post&#x2010;hospitalisation COVID&#x2010;19 cases. Int J Audiol. 2020;59:889&#x2010;890. doi:10.1080/14992027.2020.1798519</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2020.1798519</ArticleId><ArticleId IdType="pubmed">32735466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruts L, Drenthen J, Jacobs BC, van Doorn PA, Dutch GBS Study Group . Distinguishing acute&#x2010;onset CIDP from fluctuating Guillain&#x2010;Barre syndrome: a prospective study. Neurology. 2010;74:1680&#x2010;1686. doi:10.1212/WNL.0b013e3181e07d14</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181e07d14</ArticleId><ArticleId IdType="pubmed">20427754</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu&#x2010;Rumeileh S, Garibashvili T, Ruf W, et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID&#x2010;19. J Neurol Sci. 2020;418:117106. doi:10.1016/j.jns.2020.117106</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117106</ArticleId><ArticleId IdType="pmc">PMC7462872</ArticleId><ArticleId IdType="pubmed">32911389</ArticleId></ArticleIdList></Reference><Reference><Citation>van Looy E, Veenker L, Steyaert A, Leenders J, Malfroid G, de Cauwer H. COVID&#x2010;19&#x2010;induced exacerbation of chronic inflammatory demyelinating polyneuropathy. J Neurol. 2021;268(9):3129&#x2010;3131. doi:10.1007/s00415-021-10417-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10417-9</ArticleId><ArticleId IdType="pmc">PMC7892325</ArticleId><ArticleId IdType="pubmed">33606069</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Bridgewood C, Ramanan AV, Meaney JFM, Watad A. COVID&#x2010;19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021;3:e224&#x2010;e233. doi:10.1016/S2665-9913(20)30420-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30420-3</ArticleId><ArticleId IdType="pmc">PMC7832717</ArticleId><ArticleId IdType="pubmed">33521655</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E, Newcombe V, Michell A, et al. Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID&#x2010;19. J Neurol. 2021;268(8):2685&#x2010;2689. doi:10.1007/s00415-020-10321-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10321-8</ArticleId><ArticleId IdType="pmc">PMC7690651</ArticleId><ArticleId IdType="pubmed">33244712</ArticleId></ArticleIdList></Reference><Reference><Citation>Enrique Est&#xe9;vez&#x2010;Rivera JB&#x2010;H, Rubiano H, Garc&#xed;a&#x2010;Perdomo HA. Mononeuritis multiplex associated with Sars&#x2010;Cov2&#x2010;Covid&#x2010;19 Infection: case report. Int J Neurol Neurother. 2020;7:102&#x2010;105. doi:10.23937/2378-3001/1410102</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2378-3001/1410102</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman SB, Klochko CL, Dhillon MK, Vandermissen NR, van Holsbeeck MT. Peripheral polyneuropathy associated with COVID&#x2010;19 in two patients: A musculoskeletal ultrasound case report. J Med Ultrasound. 2020;28:249&#x2010;252. doi:10.4103/JMU.JMU_150_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/JMU.JMU_150_20</ArticleId><ArticleId IdType="pmc">PMC7869729</ArticleId><ArticleId IdType="pubmed">33659166</ArticleId></ArticleIdList></Reference><Reference><Citation>Han CY, Tarr AM, Gewirtz AN, et al. Brachial plexopathy as a complication of COVID&#x2010;19. BMJ Case Rep. 2021;14(3):e237459. doi:10.1136/bcr-2020-237459</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237459</ArticleId><ArticleId IdType="pmc">PMC8006770</ArticleId><ArticleId IdType="pubmed">33766961</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroun MW, Dieiev V, Kang J, et al. Rhabdomyolysis in COVID&#x2010;19 patients: a retrospective observational study. Cureus. 2021;13:e12552. doi:10.7759/cureus.12552</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12552</ArticleId><ArticleId IdType="pmc">PMC7869906</ArticleId><ArticleId IdType="pubmed">33575135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamzouri O, Bouchlarhem A, Haddar L, et al. SARS&#x2010;CoV&#x2010;2 infection presenting as rhabdomyolysis: case report and review. J Int Med Res. 2021;49:3000605211061035. doi:10.1177/03000605211061035</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605211061035</ArticleId><ArticleId IdType="pmc">PMC8652189</ArticleId><ArticleId IdType="pubmed">34871534</ArticleId></ArticleIdList></Reference><Reference><Citation>Taxbro K, Kahlow H, Wulcan H, Fornarve A. Rhabdomyolysis and acute kidney injury in severe COVID&#x2010;19 infection. BMJ Case Rep. 2020;13(9):e237616. doi:10.1136/bcr-2020-237616</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-237616</ArticleId><ArticleId IdType="pmc">PMC7470512</ArticleId><ArticleId IdType="pubmed">32878841</ArticleId></ArticleIdList></Reference><Reference><Citation>Beydon M, Chevalier K, al Tabaa O, et al. Myositis as a manifestation of SARS&#x2010;CoV&#x2010;2. Ann Rheum Dis. 2020;annrheumdis&#x2010;2020&#x2010;217573. doi:10.1136/annrheumdis-2020-217573</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217573</ArticleId><ArticleId IdType="pubmed">32327427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Shan KS, Minalyan A, O'Sullivan C, Nace T. A rare presentation of coronavirus disease 2019 (COVID&#x2010;19) induced viral myositis with subsequent rhabdomyolysis. Cureus. 2020;12:e8074. doi:10.7759/cureus.8074</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8074</ArticleId><ArticleId IdType="pmc">PMC7290109</ArticleId><ArticleId IdType="pubmed">32542129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Charmchi Z, Seidman RJ, Anziska Y, Velayudhan V, Perk J. COVID&#x2010;19&#x2010;associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020;62:E57&#x2010;E60. doi:10.1002/mus.27003</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27003</ArticleId><ArticleId IdType="pmc">PMC7323133</ArticleId><ArticleId IdType="pubmed">32535934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale Y, Patankar A, Holla U, et al. Dermatomyositis during COVID&#x2010;19 Pandemic (a case series): is there a cause effect relationship? J Assoc Physicians India. 2020;68:20&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33187031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehan WA, Yoon BC, Lang M, Li MD, Rincon S, Buch K. Paraspinal myositis in patients with COVID&#x2010;19 infection. AJNR Am J Neuroradiol. 2020;41:1949&#x2010;1952. doi:10.3174/ajnr.A6711</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6711</ArticleId><ArticleId IdType="pmc">PMC7661075</ArticleId><ArticleId IdType="pubmed">32763902</ArticleId></ArticleIdList></Reference><Reference><Citation>Almadani M, Shiferson A, Swearingen B, Shih M, Jacob T, Rhee R. Compartment syndrome secondary to viral myositis as initial presentation in COVID&#x2010;19 patient. J Vasc Surg Cases Innov Tech. 2020;6:524&#x2010;527. doi:10.1016/j.jvscit.2020.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvscit.2020.08.021</ArticleId><ArticleId IdType="pmc">PMC7462888</ArticleId><ArticleId IdType="pubmed">32904963</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam B, Ahmed M, Islam Z, Begum SM. Severe acute myopathy following SARS&#x2010;CoV&#x2010;2 infection: a case report and review of recent literature. Skelet Muscle. 2021;11:10. doi:10.1186/s13395-021-00266-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-021-00266-5</ArticleId><ArticleId IdType="pmc">PMC8058144</ArticleId><ArticleId IdType="pubmed">33883014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura M, Sugimoto H. Clinically amyopathic dermatomyositis during the COVID&#x2010;19 pandemic. Oxf Med Case Reports. 2021;omab061:2021. doi:10.1093/omcr/omab061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/omcr/omab061</ArticleId><ArticleId IdType="pmc">PMC8365844</ArticleId><ArticleId IdType="pubmed">34408884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M, Zhang S, Chu D, et al. COVID&#x2010;19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report. BMC Pulm Med. 2020;20:304. doi:10.1186/s12890-020-01335-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01335-z</ArticleId><ArticleId IdType="pmc">PMC7675391</ArticleId><ArticleId IdType="pubmed">33213393</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte&#x2010;Neto AN, Monteiro RAA, da Silva LFF, et al. Pulmonary and systemic involvement in COVID&#x2010;19 patients assessed with ultrasound&#x2010;guided minimally invasive autopsy. Histopathology. 2020;77:186&#x2010;197. doi:10.1111/his.14160</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14160</ArticleId><ArticleId IdType="pmc">PMC7280721</ArticleId><ArticleId IdType="pubmed">32443177</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID&#x2010;19: a novel case report and literature review. J Neurol. 2020;268(8):2690&#x2010;2696. doi:10.1007/s00415-020-10263-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10263-1</ArticleId><ArticleId IdType="pmc">PMC7549728</ArticleId><ArticleId IdType="pubmed">33047223</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo DA, Centonze D, Alesina A, Marchese&#x2010;Ragona R. Myasthenia gravis associated with SARS&#x2010;CoV&#x2010;2 infection. Ann Intern Med. 2020;173:1027&#x2010;1028. doi:10.7326/L20-0845</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-0845</ArticleId><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber M, Rogozinski S, Puppe W, et al. Postinfectious onset of myasthenia gravis in a COVID&#x2010;19 patient. Front Neurol. 2020;11:576153. doi:10.3389/fneur.2020.576153</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.576153</ArticleId><ArticleId IdType="pmc">PMC7573137</ArticleId><ArticleId IdType="pubmed">33123081</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody&#x2010;associated myasthenia gravis with SARS&#x2010;CoV&#x2010;2 infection: a case report. Ann Intern Med. 2021;174(6):872&#x2010;873. doi:10.7326/L20-1298</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-1298</ArticleId><ArticleId IdType="pmc">PMC7808439</ArticleId><ArticleId IdType="pubmed">33428437</ArticleId></ArticleIdList></Reference><Reference><Citation>Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, del Sette M. Myasthenia gravis associated with anti&#x2010;MuSK antibodies developed after SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2021;28(10):3537&#x2010;3539. doi:10.1111/ene.14721</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14721</ArticleId><ArticleId IdType="pmc">PMC8014563</ArticleId><ArticleId IdType="pubmed">33421278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushlaf H. COVID&#x2010;19 in muscle&#x2010;specific kinase myasthenia gravis: A case report. Muscle Nerve. 2020;62:E65&#x2010;E66. doi:10.1002/mus.27020</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27020</ArticleId><ArticleId IdType="pmc">PMC7404663</ArticleId><ArticleId IdType="pubmed">32658332</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P, Slama MCC, Kaku M, et al. COVID&#x2010;19 in patients with myasthenia gravis. Muscle Nerve. 2020;62:254&#x2010;258. doi:10.1002/mus.26918</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26918</ArticleId><ArticleId IdType="pmc">PMC7272991</ArticleId><ArticleId IdType="pubmed">32392389</ArticleId></ArticleIdList></Reference><Reference><Citation>Camelo&#x2010;Filho AE, Silva AMS, Estephan EP, et al. Myasthenia gravis and COVID&#x2010;19: clinical characteristics and outcomes. Front Neurol. 2020;11:1053. doi:10.3389/fneur.2020.01053</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01053</ArticleId><ArticleId IdType="pmc">PMC7516054</ArticleId><ArticleId IdType="pubmed">33013676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers A, Lascano AM, Lalive PH. Management of patients with generalised myasthenia gravis and COVID&#x2010;19: four case reports. J Neurol Neurosurg Psychiatry. 2020;91:1124&#x2010;1125. doi:10.1136/jnnp-2020-323565</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323565</ArticleId><ArticleId IdType="pubmed">32651248</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy B, Kovvuru S, Nalleballe K, Onteddu SR, Nowak RJ. Electronic health record derived&#x2010;impact of COVID&#x2010;19 on myasthenia gravis. J Neurol Sci. 2021;423:117362. doi:10.1016/j.jns.2021.117362</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117362</ArticleId><ArticleId IdType="pmc">PMC7895699</ArticleId><ArticleId IdType="pubmed">33639420</ArticleId></ArticleIdList></Reference><Reference><Citation>Muppidi S, Guptill JT, Jacob S, et al. COVID&#x2010;19&#x2010;associated risks and effects in myasthenia gravis (CARE&#x2010;MG). Lancet Neurol. 2020;19:970&#x2010;971. doi:10.1016/S1474-4422(20)30413-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30413-0</ArticleId><ArticleId IdType="pmc">PMC7837033</ArticleId><ArticleId IdType="pubmed">33212055</ArticleId></ArticleIdList></Reference><Reference><Citation>Businaro P, Vaghi G, Marchioni E, et al. COVID&#x2010;19 in patients with myasthenia gravis: epidemiology and disease course. Muscle Nerve. 2021;64:206&#x2010;211. doi:10.1002/mus.27324</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27324</ArticleId><ArticleId IdType="pmc">PMC8242475</ArticleId><ArticleId IdType="pubmed">34031902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe9; G, Mathis S, Friedman D, et al. Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis. Neurology. 2021;96:e2109&#x2010;e2120. doi:10.1212/WNL.0000000000011669</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011669</ArticleId><ArticleId IdType="pubmed">33568541</ArticleId></ArticleIdList></Reference><Reference><Citation>Saied Z, Rachdi A, Thamlaoui S, et al. Myasthenia gravis and COVID&#x2010;19: A case series and comparison with literature. Acta Neurol Scand. 2021;144:334&#x2010;340. doi:10.1111/ane.13440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13440</ArticleId><ArticleId IdType="pmc">PMC8222886</ArticleId><ArticleId IdType="pubmed">33914898</ArticleId></ArticleIdList></Reference><Reference><Citation>Caba&#xf1;es&#x2010;Mart&#xed;nez L, Villad&#xf3;niga M, Gonz&#xe1;lez&#x2010;Rodr&#xed;guez L, et al. Neuromuscular involvement in COVID&#x2010;19 critically ill patients. Clin Neurophysiol. 2020;131:2809&#x2010;2816. doi:10.1016/j.clinph.2020.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.09.017</ArticleId><ArticleId IdType="pmc">PMC7558229</ArticleId><ArticleId IdType="pubmed">33137571</ArticleId></ArticleIdList></Reference><Reference><Citation>Madia F, Merico B, Primiano G, Cutuli SL, de Pascale G, Servidei S. Acute myopathic quadriplegia in patients with COVID&#x2010;19 in the intensive care unit. Neurology. 2020;95:492&#x2010;494. doi:10.1212/WNL.0000000000010280</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010280</ArticleId><ArticleId IdType="pubmed">32601119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharebaghi N, Nejadrahim R, Mousavi SJ, Sadat&#x2010;Ebrahimi SR, Hajizadeh R. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo&#x2010;controlled double&#x2010;blind clinical trial. BMC Infect Dis. 2020;20:786. doi:10.1186/s12879-020-05507-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05507-4</ArticleId><ArticleId IdType="pmc">PMC7576972</ArticleId><ArticleId IdType="pubmed">33087047</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoian A, Bajko Z, Maier S, et al. High&#x2010;dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS&#x2010;CoV&#x2010;2 infection: A case&#x2010;based review of the literature (Review). Exp Ther Med. 2021;22:1182. doi:10.3892/etm.2021.10616</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.10616</ArticleId><ArticleId IdType="pmc">PMC8406741</ArticleId><ArticleId IdType="pubmed">34475972</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;rin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159&#x2010;2168. doi:10.1056/NEJMoa1214103</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1214103</ArticleId><ArticleId IdType="pubmed">23688302</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik GR, Wolfe AR, Soriano R, et al. Injury&#x2010;prone: peripheral nerve injuries associated with prone positioning for COVID&#x2010;19&#x2010;related acute respiratory distress syndrome. Br J Anaesth. 2020;125:e478&#x2010;e480. doi:10.1016/j.bja.2020.08.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.08.045</ArticleId><ArticleId IdType="pmc">PMC7473147</ArticleId><ArticleId IdType="pubmed">32948295</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugliera L, Filippi M, del Carro U, et al. Nerve compression injuries after prolonged prone position ventilation in patients with SARS&#x2010;CoV&#x2010;2: a case series. Arch Phys Med Rehabil. 2021;102:359&#x2010;362. doi:10.1016/j.apmr.2020.10.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.10.131</ArticleId><ArticleId IdType="pmc">PMC7685952</ArticleId><ArticleId IdType="pubmed">33245939</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller C, O'Sullivan J, Jeffrey J, Power D. Brachial plexus neuropathies during the COVID&#x2010;19 pandemic: a retrospective case series of 15 patients in critical care. Phys Ther. 2021;101(1):pzaa191. doi:10.1093/ptj/pzaa191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzaa191</ArticleId><ArticleId IdType="pmc">PMC7665709</ArticleId><ArticleId IdType="pubmed">33395478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayegh MJ, Larsen CG, Pinpin C, Intravia JM, Nellans KW. Ulnar neuropathy after intermittent prone positioning for COVID&#x2010;19 infection: A preliminary report of 3 cases. JBJS Case Connect. 2021;11(1). doi:10.2106/JBJS.CC.20.00729</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.CC.20.00729</ArticleId><ArticleId IdType="pubmed">33739958</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez&#x2010;Soblechero A, Garc&#xed;a CA, S&#xe1;ez Ansotegui A, et al. Upper trunk brachial plexopathy as a consequence of prone positioning due to SARS&#x2010;CoV&#x2010;2 acute respiratory distress syndrome. Muscle Nerve. 2020;62:E76&#x2010;E78. doi:10.1002/mus.27055</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27055</ArticleId><ArticleId IdType="pubmed">32875575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Siao P. Lateral femoral cutaneous neuropathy caused by prone positioning to treat COVID&#x2010;19&#x2010;associated acute respiratory distress syndrome. Muscle Nerve. 2021;63(6):E50&#x2010;E52. doi:10.1002/mus.27202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27202</ArticleId><ArticleId IdType="pmc">PMC8014439</ArticleId><ArticleId IdType="pubmed">33577110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinghausen AL, LaBuzetta J, Chu F, Novelli F, Rodelo AR, Owens RL. Lessons from an ICU recovery clinic: two cases of meralgia paresthetica after prone positioning to treat COVID&#x2010;19&#x2010;associated ARDS and modification of unit practices. Crit Care. 2020;24:580. doi:10.1186/s13054-020-03289-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03289-4</ArticleId><ArticleId IdType="pmc">PMC7520164</ArticleId><ArticleId IdType="pubmed">32981525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27:601&#x2010;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod&#x2010;Artal FJ. Post&#x2010;COVID&#x2010;19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021;72:384&#x2010;396. doi:10.33588/rn.7211.2021230</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.7211.2021230</ArticleId><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group , Morin L, Savale L, et al. Four&#x2010;month clinical status of a cohort of patients after hospitalization for COVID&#x2010;19. JAMA. 2021;325:1525&#x2010;1534. doi:10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, et al. Long COVID in a prospective cohort of home&#x2010;isolated patients. Nat Med. 2021;27:1607&#x2010;1613. doi:10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID&#x2010;19. Brain. 2021;144:1263&#x2010;1276. doi:10.1093/brain/awab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, Malsy J, P&#xf6;ttgen J, et al. Frequent neurocognitive deficits after recovery from mild COVID&#x2010;19. Brain Commun. 2020;2:fcaa205. doi:10.1093/braincomms/fcaa205</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer&#x2010;Frie&#xdf;em CH, Gierthm&#xfc;hlen J, Baron R, Sommer C, &#xdc;&#xe7;eyler N, Enax&#x2010;Krumova EK. Pain during and after COVID&#x2010;19 in Germany and worldwide: a narrative review of current knowledge. Pain Rep. 2021;6:e893. doi:10.1097/PR9.0000000000000893</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000893</ArticleId><ArticleId IdType="pmc">PMC7819701</ArticleId><ArticleId IdType="pubmed">33490851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar NB. Does COVID&#x2010;19&#x2010;related cachexia mimic cancer&#x2010;related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management. J Cachexia Sarcopenia Muscle. 2021;12:519&#x2010;522. doi:10.1002/jcsm.12681</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12681</ArticleId><ArticleId IdType="pmc">PMC8013485</ArticleId><ArticleId IdType="pubmed">33554483</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C&#x2010;P&#x2010;ACSG. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324:603&#x2010;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID&#x2010;19 infection: a case series of 20 patients. Immunol Res. 2021;69:205&#x2010;211. doi:10.1007/s12026-021-09185-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021;21:e63&#x2010;e67. doi:10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID&#x2010;19 infection: an early experience. Clin Auton Res. 2021;31:385&#x2010;394. doi:10.1007/s10286-021-00803-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinduja A, Moutairou A, Calvet JH. Sudomotor dysfunction in patients recovered from COVID&#x2010;19. Neurophysiol Clin. 2021;51:193&#x2010;196. doi:10.1016/j.neucli.2021.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7835104</ArticleId><ArticleId IdType="pubmed">33551341</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS&#x2010;CoV&#x2010;2 infection. Muscle Nerve. 2021. doi:10.1002/mus.27458</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96:2861&#x2010;2878. doi:10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. Post&#x2010;infective and chronic fatigue syndromes precipitated by viral and non&#x2010;viral pathogens: prospective cohort study. BMJ. 2006;333:575. doi:10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid&#x2010;19 vaccine. N Engl J Med. 2020;383:2603&#x2010;2615. doi:10.1056/NEJMoa2034577</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden LR, el Sahly HM, Essink B, et al. Efficacy and safety of the mRNA&#x2010;1273 SARS&#x2010;CoV&#x2010;2 vaccine. N Engl J Med. 2021;384:403&#x2010;416. doi:10.1056/NEJMoa2035389</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadoff J, le Gars M, Shukarev G, et al. Interim results of a phase 1&#x2010;2a trial of Ad26.COV2.S Covid&#x2010;19 vaccine. N Engl J Med. 2021;384(19):1824&#x2010;1835. doi:10.1056/NEJMoa2034201</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034201</ArticleId><ArticleId IdType="pmc">PMC7821985</ArticleId><ArticleId IdType="pubmed">33440088</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV&#x2010;19 vaccine (AZD1222) against SARS&#x2010;CoV&#x2010;2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99&#x2010;111. doi:10.1016/S0140-6736(20)32661-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32661-1</ArticleId><ArticleId IdType="pmc">PMC7723445</ArticleId><ArticleId IdType="pubmed">33306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector&#x2010;based heterologous prime&#x2010;boost COVID&#x2010;19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397:671&#x2010;681. doi:10.1016/S0140-6736(21)00234-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00234-8</ArticleId><ArticleId IdType="pmc">PMC7852454</ArticleId><ArticleId IdType="pubmed">33545094</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of NVX&#x2010;CoV2373 Covid&#x2010;19 vaccine. N Engl J Med. 2021;385:1172&#x2010;1183. doi:10.1056/NEJMoa2107659</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107659</ArticleId><ArticleId IdType="pmc">PMC8262625</ArticleId><ArticleId IdType="pubmed">34192426</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, Duan K, Zhang Y, et al. Effect of an inactivated vaccine against SARS&#x2010;CoV&#x2010;2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA. 2020;324:951&#x2010;960. doi:10.1001/jama.2020.15543</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.15543</ArticleId><ArticleId IdType="pmc">PMC7426884</ArticleId><ArticleId IdType="pubmed">32789505</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Huang R, Sy LS, et al. COVID&#x2010;19 vaccination and non&#x2010;COVID&#x2010;19 mortality risk&#x2014;seven integrated health care organizations, United States, December 14, 2020&#x2010;July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1520&#x2010;1524. doi:10.15585/mmwr.mm7043e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7043e2</ArticleId><ArticleId IdType="pmc">PMC8553028</ArticleId><ArticleId IdType="pubmed">34710075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID&#x2010;19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices &#x2010; United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:977&#x2010;982. doi:10.15585/mmwr.mm7027e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7027e2</ArticleId><ArticleId IdType="pmc">PMC8312754</ArticleId><ArticleId IdType="pubmed">34237049</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G, Barda N, Hoss S, et al. Myocarditis after Covid&#x2010;19 vaccination in a large health care organization. N Engl J Med. 2021;385:2132&#x2010;2139. doi:10.1056/NEJMoa2110737</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110737</ArticleId><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain&#x2010;Barre syndrome. Drug Saf. 2009;32:309&#x2010;323. doi:10.2165/00002018-200932040-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002018-200932040-00005</ArticleId><ArticleId IdType="pubmed">19388722</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain&#x2010;Barre syndrome in the placebo and active arms of a COVID&#x2010;19 vaccine clinical trial: temporal associations do not imply causality. Neurology. 2021. doi:10.1212/WNL.0000000000011881</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011881</ArticleId><ArticleId IdType="pubmed">33824169</ArticleId></ArticleIdList></Reference><Reference><Citation>Theuriet J, Richard C, Becker J, Pegat A, Bernard E, Vukusic S. Guillain&#x2010;Barre syndrome following first injection of ChAdOx1 nCoV&#x2010;19 vaccine: first report. Rev Neurol (Paris). 2021;177:1305&#x2010;1307. doi:10.1016/j.neurol.2021.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2021.04.005</ArticleId><ArticleId IdType="pubmed">34217513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbebor O, Seth H, Min Z, Bhanot N. Guillain&#x2010;Barre syndrome following the first dose of SARS&#x2010;CoV&#x2010;2 vaccine: a temporal occurrence, not a causal association. IDCases. 2021;24:e01143. doi:10.1016/j.idcr.2021.e01143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2021.e01143</ArticleId><ArticleId IdType="pmc">PMC8086372</ArticleId><ArticleId IdType="pubmed">33968610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan T, Khan M, Khan F, Hamza G. Case of Guillain&#x2010;Barre syndrome following COVID&#x2010;19 vaccine. BMJ Case Rep. 2021;14(6):e243629. doi:10.1136/bcr-2021-243629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243629</ArticleId><ArticleId IdType="pmc">PMC8245439</ArticleId><ArticleId IdType="pubmed">34187803</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SU, Khurram R, Lakhani A, Quirk B. Guillain&#x2010;Barre syndrome following the first dose of the chimpanzee adenovirus&#x2010;vectored COVID&#x2010;19 vaccine, ChAdOx1. BMJ Case Rep. 2021;14(4):e242956. doi:10.1136/bcr-2021-242956</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-242956</ArticleId><ArticleId IdType="pmc">PMC8070856</ArticleId><ArticleId IdType="pubmed">33888484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutar NK, Eyigurbuz T, Yildirim Z, Kale N. A variant of Guillain&#x2010;Barre syndrome after SARS&#x2010;CoV&#x2010;2 vaccination: AMSAN. Ideggyogy Sz. 2021;74:286&#x2010;288. doi:10.18071/isz.74.0286</Citation><ArticleIdList><ArticleId IdType="doi">10.18071/isz.74.0286</ArticleId><ArticleId IdType="pubmed">34370408</ArticleId></ArticleIdList></Reference><Reference><Citation>Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID&#x2010;19: Guillain&#x2010;Barre syndrome following Pfizer COVID&#x2010;19 vaccine. Cureus. 2021;13:e13426. doi:10.7759/cureus.13426</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13426</ArticleId><ArticleId IdType="pmc">PMC7978140</ArticleId><ArticleId IdType="pubmed">33758714</ArticleId></ArticleIdList></Reference><Reference><Citation>Razok A, Shams A, Almeer A, Zahid M. Post&#x2010;COVID&#x2010;19 vaccine Guillain&#x2010;Barre syndrome; first reported case from Qatar. Ann Med Surg (Lond). 2021;67:102540. doi:10.1016/j.amsu.2021.102540</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102540</ArticleId><ArticleId IdType="pmc">PMC8253659</ArticleId><ArticleId IdType="pubmed">34249353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasuelli NA, de Marchi F, Cecchin M, et al. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV&#x2010;19 vaccine. Neurol Sci. 2021;42:4747&#x2010;4749. doi:10.1007/s10072-021-05467-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05467-w</ArticleId><ArticleId IdType="pmc">PMC8285283</ArticleId><ArticleId IdType="pubmed">34272622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacio GB, Patel D, Cook S, et al. Bilateral facial weakness with paraesthesia variant of Guillain&#x2010;Barre syndrome following Vaxzevria COVID&#x2010;19 vaccine. J Neurol Neurosurg Psychiatry. 2021;jnnp&#x2010;2021&#x2010;327027. doi:10.1136/jnnp-2021-327027</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327027</ArticleId><ArticleId IdType="pubmed">34261746</ArticleId></ArticleIdList></Reference><Reference><Citation>McKean N, Chircop C. Guillain&#x2010;Barre syndrome after COVID&#x2010;19 vaccination. BMJ Case Rep. 2021;14(7):e244125. doi:10.1136/bcr-2021-244125</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244125</ArticleId><ArticleId IdType="pmc">PMC8327820</ArticleId><ArticleId IdType="pubmed">34330729</ArticleId></ArticleIdList></Reference><Reference><Citation>James J, Jose J, Gafoor VA, Smita B, Balaram N. Guillain&#x2010;Barre syndrome following ChAdOx1 nCoV&#x2010;19 COVID&#x2010;19 vaccination: A case series. Neurol Clin Neurosci. 2021;9:402&#x2010;405. doi:10.1111/ncn3.12537</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12537</ArticleId><ArticleId IdType="pmc">PMC8447386</ArticleId><ArticleId IdType="pubmed">34548920</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain&#x2010;Barre syndrome following BNT162b2 COVID&#x2010;19 vaccine. Neurol Sci. 2021;42:4401&#x2010;4402. doi:10.1007/s10072-021-05523-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05523-5</ArticleId><ArticleId IdType="pmc">PMC8331323</ArticleId><ArticleId IdType="pubmed">34346014</ArticleId></ArticleIdList></Reference><Reference><Citation>Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain&#x2010;Barre syndrome after second dose of Pfizer COVID&#x2010;19 vaccine. Hum Vaccin Immunother. 2021;17(11):4093&#x2010;40. doi:10.1080/21645515.2021.1954826</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1954826</ArticleId><ArticleId IdType="pmc">PMC8828152</ArticleId><ArticleId IdType="pubmed">34347563</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo WM, Giri P, de Souza A. AstraZeneca COVID&#x2010;19 vaccine and Guillain&#x2010;Barre syndrome in Tasmania: a causal link? J Neuroimmunol. 2021;360:577719. doi:10.1016/j.jneuroim.2021.577719</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577719</ArticleId><ArticleId IdType="pmc">PMC8447540</ArticleId><ArticleId IdType="pubmed">34560365</ArticleId></ArticleIdList></Reference><Reference><Citation>Min YG, Ju W, Ha YE, et al. Sensory Guillain&#x2010;Barre syndrome following the ChAdOx1 nCov&#x2010;19 vaccine: Report of two cases and review of literature. J Neuroimmunol. 2021;359:577691. doi:10.1016/j.jneuroim.2021.577691</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577691</ArticleId><ArticleId IdType="pmc">PMC8349403</ArticleId><ArticleId IdType="pubmed">34416410</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo LK, Salim O, Liang D, et al. Acute&#x2010;onset polyradiculoneuropathy after SARS&#x2010;CoV2 vaccine in the West and North Midlands, United Kingdom. Muscle Nerve. 2022;65(2):233&#x2010;237. doi:10.1002/mus.27461</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27461</ArticleId><ArticleId IdType="pmc">PMC8661585</ArticleId><ArticleId IdType="pubmed">34786740</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen CM, Ramsamy S, Tarr AW, et al. Guillain&#x2010;Barre Syndrome variant occurring after SARS&#x2010;CoV&#x2010;2 vaccination. Ann Neurol. 2021;90:315&#x2010;318. doi:10.1002/ana.26144</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26144</ArticleId><ArticleId IdType="pubmed">34114269</ArticleId></ArticleIdList></Reference><Reference><Citation>Maramattom BV, Krishnan P, Paul R, et al. Guillain&#x2010;Barre syndrome following ChAdOx1&#x2010;S/nCoV&#x2010;19 vaccine. Ann Neurol. 2021;90:312&#x2010;314. doi:10.1002/ana.26143</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26143</ArticleId><ArticleId IdType="pubmed">34114256</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo EJ, Mba&#x2010;Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of receipt of the Ad26.COV2.S COVID&#x2010;19 vaccine with presumptive Guillain&#x2010;Barre syndrome, February&#x2010;July 2021. JAMA. 2021;326:1606&#x2010;1613. doi:10.1001/jama.2021.16496</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.16496</ArticleId><ArticleId IdType="pmc">PMC8498927</ArticleId><ArticleId IdType="pubmed">34617967</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of COVID&#x2010;19 vaccines and SARS&#x2010;CoV&#x2010;2 infection. Nat Med. 2021;27:2144&#x2010;2153. doi:10.1038/s41591-021-01556-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01556-7</ArticleId><ArticleId IdType="pmc">PMC8629105</ArticleId><ArticleId IdType="pubmed">34697502</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain&#x2010;Barre syndrome associated with COVID&#x2010;19 vaccination. Emerg Infect Dis. 2021;27:3175&#x2010;3178. doi:10.3201/eid2712.211634</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2712.211634</ArticleId><ArticleId IdType="pmc">PMC8632191</ArticleId><ArticleId IdType="pubmed">34648420</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;Grimshaw M, Vera&#x2010;Zertuche JM, Galnares&#x2010;Olalde JA, et al. Guillain&#x2010;Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID&#x2010;19 vaccine. Clin Immunol. 2021;230:108818. doi:10.1016/j.clim.2021.108818</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108818</ArticleId><ArticleId IdType="pmc">PMC8332675</ArticleId><ArticleId IdType="pubmed">34358692</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein NP, Lewis N, Goddard K, et al. Surveillance for adverse events after COVID&#x2010;19 mRNA vaccination. JAMA. 2021;326:1390&#x2010;1399. doi:10.1001/jama.2021.15072</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.15072</ArticleId><ArticleId IdType="pmc">PMC8511971</ArticleId><ArticleId IdType="pubmed">34477808</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, De Marco G, Bridgewood C. Mechanisms of Immunothrombosis in vaccine&#x2010;induced thrombotic thrombocytopenia (VITT) compared to natural SARS&#x2010;CoV&#x2010;2 infection. J Autoimmun. 2021;121:102662. doi:10.1016/j.jaut.2021.102662</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102662</ArticleId><ArticleId IdType="pmc">PMC8133385</ArticleId><ArticleId IdType="pubmed">34051613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn MP, Cornblath DR, Jacobs BC, et al. COVID&#x2010;19 vaccine and Guillain&#x2010;Barre syndrome: let's not leap to associations. Brain. 2021;144:357&#x2010;360. doi:10.1093/brain/awaa444</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa444</ArticleId><ArticleId IdType="pmc">PMC7799242</ArticleId><ArticleId IdType="pubmed">33313690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain&#x2010;Barre syndrome: a systematic review and meta&#x2010;analysis. Neuroepidemiology. 2011;36:123&#x2010;133. doi:10.1159/000324710</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000324710</ArticleId><ArticleId IdType="pmc">PMC5703046</ArticleId><ArticleId IdType="pubmed">21422765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozonoff A, Nanishi E, Levy O. Bell's palsy and SARS&#x2010;CoV&#x2010;2 vaccines. Lancet Infect Dis. 2021;21:450&#x2010;452. doi:10.1016/S1473-3099(21)00076-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00076-1</ArticleId><ArticleId IdType="pmc">PMC7906673</ArticleId><ArticleId IdType="pubmed">33639103</ArticleId></ArticleIdList></Reference><Reference><Citation>Colella G, Orlandi M, Cirillo N. Bell's palsy following COVID&#x2010;19 vaccination. J Neurol. 2021;268(10):3589&#x2010;3591. doi:10.1007/s00415-021-10462-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10462-4</ArticleId><ArticleId IdType="pmc">PMC7897359</ArticleId><ArticleId IdType="pubmed">33611630</ArticleId></ArticleIdList></Reference><Reference><Citation>Repajic M, Lai XL, Xu P, Liu A. Bell's Palsy after second dose of Pfizer COVID&#x2010;19 vaccination in a patient with history of recurrent Bell's palsy. Brain Behav Immun Health. 2021;13:100217. doi:10.1016/j.bbih.2021.100217</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100217</ArticleId><ArticleId IdType="pmc">PMC7874945</ArticleId><ArticleId IdType="pubmed">33594349</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrows A, Bartholomew T, Rudd J, Walker D. Sequential contralateral facial nerve palsies following COVID&#x2010;19 vaccination first and second doses. BMJ Case Rep. 2021;14(7):e243829. doi:10.1136/bcr-2021-243829</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243829</ArticleId><ArticleId IdType="pmc">PMC8291314</ArticleId><ArticleId IdType="pubmed">34281950</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemer A, Pras E, Hecht I. Peripheral facial nerve palsy following BNT162b2 (COVID&#x2010;19) vaccination. Isr Med Assoc J. 2021;23:143&#x2010;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">33734623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawar N, Maheshwari D, Ravindran M, Padmavathy S. Ophthalmic complications of COVID&#x2010;19 vaccination. Indian J Ophthalmol. 2021;69:2900&#x2010;2902. doi:10.4103/ijo.IJO_2122_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_2122_21</ArticleId><ArticleId IdType="pmc">PMC8597492</ArticleId><ArticleId IdType="pubmed">34571680</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes&#x2010;Capo DP, Stevens SM, Cavuoto KM. Acute abducens nerve palsy following COVID&#x2010;19 vaccination. J AAPOS. 2021;25:302&#x2010;303. doi:10.1016/j.jaapos.2021.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaapos.2021.05.003</ArticleId><ArticleId IdType="pmc">PMC8142812</ArticleId><ArticleId IdType="pubmed">34044114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawar N, Ravindran M, Padmavathy S, Chakrabarty S. Acute abducens nerve palsy after COVID&#x2010;19 vaccination in a young adult. Indian J Ophthalmol. 2021;69:3764&#x2010;3766. doi:10.4103/ijo.IJO_1968_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_1968_21</ArticleId><ArticleId IdType="pmc">PMC8837376</ArticleId><ArticleId IdType="pubmed">34827043</ArticleId></ArticleIdList></Reference><Reference><Citation>Manea MM, Dragos D, Enache I, Sirbu AG, Tuta S. Multiple cranial nerve palsies following COVID&#x2010;19 vaccination&#x2010;case report. Acta Neurol Scand. 2021;145(2):257&#x2010;259. doi:10.1111/ane.13548</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13548</ArticleId><ArticleId IdType="pmc">PMC8653229</ArticleId><ArticleId IdType="pubmed">34725821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol. 2021;21:452. doi:10.1186/s12883-021-02489-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02489-x</ArticleId><ArticleId IdType="pmc">PMC8598937</ArticleId><ArticleId IdType="pubmed">34789193</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo EJ, Winiecki SK, Ou AC. Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US vaccine adverse event reporting system. Hum Vaccin Immunother. 2014;10:301&#x2010;305. doi:10.4161/hv.27032</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27032</ArticleId><ArticleId IdType="pmc">PMC4185907</ArticleId><ArticleId IdType="pubmed">24231288</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrhman Abo&#x2010;Zed AP. Guillain&#x2010;Barr&#xe9; syndrome, or acute on chronic inflammatory demyelinating polyneuropathy, following Moderna Covid&#x2010;19 vaccine. Chest. 2021;160:S1&#x2010;S2538. doi:10.1016/j.chest.2021.07.838</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.838</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri V, Pandey S, Singh J, Jena A. Acute&#x2010;onset chronic inflammatory demyelinating polyneuropathy after COVID&#x2010;19 infection and subsequent ChAdOx1 nCoV&#x2010;19 vaccination. BMJ Case Rep. 2021;14(10):e245816. doi:10.1136/bcr-2021-245816</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-245816</ArticleId><ArticleId IdType="pmc">PMC8491284</ArticleId><ArticleId IdType="pubmed">34607818</ArticleId></ArticleIdList></Reference><Reference><Citation>Doneddu PE, Cocito D, Manganelli F, et al. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. Eur J Neurol. 2020;27:136&#x2010;143. doi:10.1111/ene.14044</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14044</ArticleId><ArticleId IdType="pubmed">31325350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitwaard K, Bos&#x2010;Eyssen ME, Blomkwist&#x2010;Markens PH, van Doorn PA. Recurrences, vaccinations and long&#x2010;term symptoms in GBS and CIDP. J Peripher Nerv Syst. 2009;14:310&#x2010;315. doi:10.1111/j.1529-8027.2009.00243.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1529-8027.2009.00243.x</ArticleId><ArticleId IdType="pubmed">20021573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard J, Mukherjee R, Hughes RA. Risk of relapse of Guillain&#x2010;Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurg Psychiatry. 2002;73:348&#x2010;349. doi:10.1136/jnnp.73.3.348</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.3.348</ArticleId><ArticleId IdType="pmc">PMC1738021</ArticleId><ArticleId IdType="pubmed">12185184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RA, Choudhary PP, Osborn M, Rees JH, Sanders EA. Immunization and risk of relapse of Guillain&#x2010;Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1996;19:1230&#x2010;1231.</Citation><ArticleIdList><ArticleId IdType="pubmed">8761286</ArticleId></ArticleIdList></Reference><Reference><Citation>Victoria Chisholm NB, Smith TM. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and vaccinations: examining the current literature on vaccinations and the onset or worsening of CIDP symptoms. touchNeurology. 2021;17:3&#x2010;5. doi:10.17925/USN.2021.17.1.3</Citation><ArticleIdList><ArticleId IdType="doi">10.17925/USN.2021.17.1.3</ArticleId></ArticleIdList></Reference><Reference><Citation>See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA. 2021;325:2448&#x2010;2456. doi:10.1001/jama.2021.7517</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7517</ArticleId><ArticleId IdType="pmc">PMC8087975</ArticleId><ArticleId IdType="pubmed">33929487</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffman JR, Randolph AC, Somerson JS. Parsonage&#x2010;Turner syndrome after SARS&#x2010;CoV&#x2010;2 BNT162b2 vaccine: a case report. JBJS Case Connect. 2021;11(3). doi:10.2106/JBJS.CC.21.00370</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.CC.21.00370</ArticleId><ArticleId IdType="pubmed">34559695</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh JS, Goh Y, Tan BY, et al. Neuralgic amyotrophy following COVID&#x2010;19 mRNA vaccination. QJM. 2021;114:503&#x2010;505. doi:10.1093/qjmed/hcab216</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab216</ArticleId><ArticleId IdType="pubmed">34347105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. Parsonage Turner syndrome after COVID&#x2010;19 vaccination. Muscle Nerve. 2021;64:E3&#x2010;E4. doi:10.1002/mus.27255</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27255</ArticleId><ArticleId IdType="pmc">PMC8250573</ArticleId><ArticleId IdType="pubmed">33890680</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitturi BK, Grandis M, Beltramini S, et al. Parsonage&#x2010;Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1&#x2010;S vaccine: a case report and review of the literature. J Med Case Rep. 2021;15:589. doi:10.1186/s13256-021-03176-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-021-03176-8</ArticleId><ArticleId IdType="pmc">PMC8667016</ArticleId><ArticleId IdType="pubmed">34903275</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz&#x2010;Segarra N, Edmond A, Gilbert C, Mckay O, Kloepping C, Yonclas P. Painless idiopathic neuralgic amyotrophy after COVID&#x2010;19 vaccination: A case report. PM R. 2021. doi:10.1002/pmrj.12619</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12619</ArticleId><ArticleId IdType="pmc">PMC8250535</ArticleId><ArticleId IdType="pubmed">33886164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SI, Seok HY, Yi J, Cho JH. Leg paralysis after AstraZeneca COVID&#x2010;19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: a case report. J Int Med Res. 2021;49:3000605211056783. doi:10.1177/03000605211056783</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605211056783</ArticleId><ArticleId IdType="pmc">PMC8649466</ArticleId><ArticleId IdType="pubmed">34816739</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespo Burillo JA, Loriente Martinez C, Garcia Arguedas C, Mora Pueyo FJ. Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID&#x2010;19 vaccine. Neurologia (Engl Ed). 2021;36:571&#x2010;572. doi:10.1016/j.nrleng.2021.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrleng.2021.05.002</ArticleId><ArticleId IdType="pmc">PMC8316086</ArticleId><ArticleId IdType="pubmed">34330677</ArticleId></ArticleIdList></Reference><Reference><Citation>Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB. Parsonage&#x2010;Turner syndrome following COVID&#x2010;19 Vaccination: MR neurography. Radiology. 2022;302:84&#x2010;87. doi:10.1148/radiol.2021211374</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211374</ArticleId><ArticleId IdType="pmc">PMC8488809</ArticleId><ArticleId IdType="pubmed">34402669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapin&#x2010;Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA&#x2010;based COVID&#x2010;19 vaccines. JAMA. 2021;325:2201&#x2010;2202. doi:10.1001/jama.2021.5374</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5374</ArticleId><ArticleId IdType="pubmed">33818592</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar M, Chung H, Dhayaparan Y, et al. COVID&#x2010;19 vaccine induced rhabdomyolysis: case report with literature review. Diabetes Metab Syndr. 2021;15:102170. doi:10.1016/j.dsx.2021.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.06.007</ArticleId><ArticleId IdType="pmc">PMC8205294</ArticleId><ArticleId IdType="pubmed">34186348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack M, Nichols L, Guerrero DM. Rhabdomyolysis secondary to COVID&#x2010;19 vaccination. Cureus. 2021;13:e15004. doi:10.7759/cureus.15004</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.15004</ArticleId><ArticleId IdType="pmc">PMC8202440</ArticleId><ArticleId IdType="pubmed">34150372</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID&#x2010;19 vaccine&#x2010;related myositis. QJM. 2021;114:424&#x2010;425. doi:10.1093/qjmed/hcab043</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab043</ArticleId><ArticleId IdType="pmc">PMC7989152</ArticleId><ArticleId IdType="pubmed">33647971</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy IRB, Rodrigues TC, Skaf A. Myositis ossificans following COVID&#x2010;19 vaccination. QJM. 2021;114:659&#x2010;660. doi:10.1093/qjmed/hcab161</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab161</ArticleId><ArticleId IdType="pmc">PMC8344502</ArticleId><ArticleId IdType="pubmed">34109386</ArticleId></ArticleIdList></Reference><Reference><Citation>Faissner S, Richter D, Ceylan U, Schneider&#x2010;Gold C, Gold R. COVID&#x2010;19 mRNA vaccine induced rhabdomyolysis and fasciitis. J Neurol. 2021;1&#x2010;2. doi:10.1007/s00415-021-10768-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10768-3</ArticleId><ArticleId IdType="pmc">PMC8386679</ArticleId><ArticleId IdType="pubmed">34435250</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post&#x2010;vaccination SARS&#x2010;CoV&#x2010;2 infection in UK users of the COVID symptom study app: a prospective, community&#x2010;based, nested, case&#x2010;control study. Lancet Infect Dis. 2022(1);22:43&#x2010;55. doi:10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295&#x2010;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1898525</ArticleId><ArticleId IdType="pubmed">14283879</ArticleId></ArticleIdList></Reference><Reference><Citation>Spallazzi M, Morelli N, Taga A. COVID&#x2010;19 and neurologic manifestations: a still missing link and a call for neurologists. Neurol Sci. 2020;41:1997&#x2010;1998. doi:10.1007/s10072-020-04540-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04540-0</ArticleId><ArticleId IdType="pmc">PMC7319910</ArticleId><ArticleId IdType="pubmed">32592104</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro Ben David S, Potasman I, Rahamim&#x2010;Cohen D. Rate of recurrent Guillain&#x2010;Barre syndrome after mRNA COVID&#x2010;19 vaccine BNT162b2. JAMA Neurol. 2021;78(11):1409&#x2010;1411. doi:10.1001/jamaneurol.2021.3287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3287</ArticleId><ArticleId IdType="pmc">PMC8411356</ArticleId><ArticleId IdType="pubmed">34468703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivkovic SA, Gruener G, Narayanaswami P, AANEM Quality and Patient Safety Committee . Doctor&#x2010;Should I get the COVID&#x2010;19 vaccine? Infection and immunization in individuals with neuromuscular disorders. Muscle Nerve. 2021;63:294&#x2010;303. doi:10.1002/mus.27179</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27179</ArticleId><ArticleId IdType="pmc">PMC8013955</ArticleId><ArticleId IdType="pubmed">33471383</ArticleId></ArticleIdList></Reference><Reference><Citation>Doneddu PE, Spina E, Briani C, et al. Acute and chronic inflammatory neuropathies and COVID&#x2010;19 vaccines: practical recommendations from the task force of the Italian Peripheral Nervous System Association (ASNP). J Peripher Nerv Syst. 2021;26(2):148&#x2010;154. doi:10.1111/jns.12435</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12435</ArticleId><ArticleId IdType="pubmed">33620123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>